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Abstract
Presently there are no effective disease-modifying treatments to combat 
neurodegeneration among chronic alcoholics. Alcohol abuse imparts a sustained 
presence of oxidative stressors, includina Dro-inflammatorv cvtokine TNFa, in the 
brain. A persistent presence of TNFa leads to an accumulation of reactive 
oxygen species, which promotes oxidative damage, subsequent 
neurodegeneration, and ultimately permanent cognitive changes in afflicted 
individuals. Our laboratory has demonstrated the potency of ursolic acid, 
isolated from Alaskan blueberries, to abolish TNFa mediated neurotoxicity in 
human neuroblastoma cells. Our current study investigated the 
neuroinflammatory effects of ethanol and TNFa on dissociated neurons and glia 
cells cultured from embryonic chicks while quantitatively evaluating the 
preventive and therapeutic effectiveness of blueberry extracts. We compared 
both CNS and PNS neurons to examine correlations to clinically indicated 
neurodegeneration. Our results clearly revealed a particular sensitivity of 
cerebellar neurons to oxidative stress; however, supplementation with blueberry 
extracts rescued neuronal health by up-regulating antioxidant defenses, 
suppressing TNFa secretion, blunting lipid peroxidation, restoring cytoskeleton 
organization, modulating lipid rafts and altering the lipid environment of ion 
channels. Implementation of blueberries into the diet may offer an inexpensive 
and safe means to improve quality of life and reduce future health care costs 
associated with alcohol abuse and neurodegenerative disease.
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Chapter 1: Purpose of Research
1.1 Significance
This study identified possible nutritional therapies capable of negating 
chronic neuroinflammation and degeneration due to alcohol abuse. Analysis 
compared different regions of the central and peripheral nervous systems to the 
cerebellum. Although the cerebellum comprises only ten percent of the brain’s 
volume, it houses half of the brain’s neurons and has been shown to be 
particularly vulnerable to alcohol abuse (Baker et al. 1999). Because the 
cerebellum is implicated in a broad spectrum of disorders including autism, 
schizophrenia, depression, and multiple movement disorders, the results of this 
study are applicable to many neurological and inflammatory disorders 
compounded and possibly induced by alcohol abuse. Oxidative stress is a 
common thread in the complex diseases associated with alcohol abuse and 
therefore interventions that disrupt the neuroinflammatory cascade are critical to 
the prevention of irreparable neuronal damage and degradation. Ursolic acid, 
isolated from natural products, has shown great promise in abutting oxidative 
stress in the liver and cardiovascular system, but very little is known about its 
ability to confer neuroprotection in the 8.1 million alcoholics living in America 
today (Saraswat et al. 2000, Mahadik et al. 2001, Saravanan et al. 2006, 
Saravanan and Pugalendi 2006). Ursolic acid and other blueberry biomolecules 
may stymie development of future neurodegenerative disease as well as 
inflammation associated with metabolic syndromes and arteriosclerosis prevalent
in alcoholics. This study advances our understanding of the neuroinflammatory 
effects of alcohol and provides a novel nutritional approach through blueberry 
supplementation to improve the overall health of alcoholics and unborn babies 
subject to maternal alcohol abuse.
1.2 Innovation
This research utilized an in vitro model system that concordantly 
determined neuron and glia specific alterations in the brain, spine, and dorsal 
root ganglia due to ethanol and TNFa exposure. Additionally, this study 
determined the effectiveness of preventive and intervening blueberry therapies 
on subsequent neuroinflammation and oxidative stress. Our approach gave a 
unique picture of how oxidative stress presents in cerebellar neurons and glia, as 
compared to other regions of the central and peripheral nervous systems. The 
embryonic chick model was used for dissociated neuronal and glial studies. Not 
only did it provide insight into the cellular mechanisms of alcohol abuse, but it 
could be further manipulated to examine the vulnerability of the developing 
cerebellum in cases of fetal alcohol syndrome. Since blueberry extracts 
drastically reduced oxidative stress and inflammatory cytokine release in our 
cellular model they may also confer protection to abusing mothers, thus sparing 
developing babies many dire consequences of maternal alcohol use.
31.3 Specific Aims
1.3.1 Summary of Specific Aims
The goal of this research was to determine whether natural products 
derived from wild Alaskan blueberries could effectively blunt the chronic 
neuroinflammatory cycle induced bv alcohol abuse. Excessive alcohol intake, 
even sporadically, results in a sustained presence of inflammatory stressors in 
the brain (Crews et al. 2006). Increasing evidence has linked neuroinflammation 
with neuronal death attributed to alcoholism, Parkinson’s disease, Alzheimer’s 
disease, multiple sclerosis, cerebellar ataxia, and other chronic disorders, either 
as the primary cause or compounding factor (Frank-Cannon et al. 2009). 
Therefore, interventions that disrupt the neuroinflammatory cascade are critical to 
the prevention of irreparable neuronal damage and degeneration.
Alcohol abuse, coupled with a dietary shift to more processed foods, may 
increase chronic inflammation and predispose individuals to neurodegenerative 
disease. Here in Alaska, the alcohol mortality rate in rural Alaska Native 
communities stands at ten times the national average and is coupled with the 
poorest nutrition and highest obesity rates within the state (Ehrlander 2010, 
Fenaughty et al. 2009). We proposed that supplementation of blueberries, highly 
enriched in the traditional Alaska Native diet, would potentially mitigate 
inflammatory stress and thus reduce the irreversible neurodegenerative effects of 
alcohol abuse.
1.3.2 Hypothesis
Chronic exposure to ethanol will induce oxidative stress, critically altering 
neuronal membranes and cytoskeleton dynamics, which in turn will produce 
permanent morphological changes and lasting behavior and motor impairment to 
such individuals. We hypothesized that natural compounds isolated from wild 
Alaska blueberries would blunt the inflammatory effects of ethanol bv restoring 
neuronal and glial membrane and cytoskeleton dynamics, reducing oxidative 
stress, and ultimately preventing irreversible neurodeoeneration.
1.3.3 Aim 1
Using the embryonic chick model, we defined the inflammatory response 
of dissociated neurons and glia to increasing concentrations of ethanol over time 
and determined the effectiveness of preventive/therapeutic strategies utilizing 
blueberry extracts (BBX) and the isolated compound, ursolic acid (UA), on 
neuroinflammation.
Ethanol neurotoxicity was assessed by quantifying oxidative stress 
through reactive oxygen species (ROS) production, tumor necrosis factor alpha 
(TNFa) production, metabolic viability, antioxidant capacity, lipid peroxidation, 
and cytoskeletal integrity in dissociated neurons and glia of the cerebellar cortex, 
forebrain cortex, spine, dorsal root ganglia (DRG), and olfactory bulb.
1.3.4 Aim 2
Using the embryonic chick model, we defined the inflammatory response 
of dissociated neurons and glia to TNFa over time and determined the 
effectiveness of preventive/therapeutic strategies of BBX and UA 
supplementation on neuroinflammation.
TNFa neurotoxicity was assessed by quantifying oxidative stress through 
ROS production, metabolic viability, antioxidant capacity, lipid peroxidation, and 
cytoskeletal integrity in dissociated neurons and glia of the cerebellar cortex, 
forebrain cortex, spine, DRG, and olfactory bulb.
1.3.5 Aim 3
Using the embryonic chick model, we quantified lipid raft modifications in 
dissociated neurons and glia of the cerebellum, forebrain, and DRGs due to 
increasing doses of ethanol and intervention with BBX and UA. Lipid rafts were 
assessed through microscopy and through quantifiable fluorescence.
1.3.6 Aim 4
Using the embryonic chick model, we quantified lipid raft modifications in 
dissociated neurons and glia of the cerebellum, forebrain, and DRGs due to 
insult with TNFa and intervention with BBX and UA. Lipid rafts were assessed 
through microscopy and quantifiable fluorescence.
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1.3.7 Aim 5
Using the embryonic chick model, we determined the effects of ethanol 
and blueberry compounds on voltage-gated sodium ion channels and their 
association with lipid rafts in cerebellar neurons. Sodium ion channels were 
assessed through microscopy, quantifiable fluorescence and enzyme linked 
immunosorbent assays (ELISA).
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7Chapter 2: General Introduction 
2.1 Neuroinflammation
The central nervous system (CNS) possesses a dynamic immune and 
inflammatory response to a variety of insults such as trauma, stroke, infection, 
and toxin exposure (Rivest 2009). Typically, an acute neuroinflammatory 
response ensues from such insults wherein microglia are activated and 
inflammatory mediators (i.e. cytokines and chemokines) are released. Although 
oxidative stress is also triggered, this temporary condition is unlikely to 
detrimentally affect long-term neuronal survival and is thus deemed beneficial to 
the CNS (Frank-Cannon et al. 2009). Chronic neuroinflammation however, elicits 
a long term self-perpetuating neuroinflammatory response that outlives the initial 
insult or injury. The continual activation of microglia and sustained release of 
inflammatory mediators exasperates the CNS’s ability to handle oxidative stress 
(Tansey et al. 2007). Chronic neuroinflammation no longer serves the protective 
role brought on by acute responses and may expose the brain to breeches of the 
blood brain barrier (BBB) (Rivest 2009).
2.2 Oxidative Stress
Oxidative stress refers to the steady state of oxidative damage caused by 
the reactive oxygen species (ROS). Oxidative stress can be isolated at the 
molecular level or affect an entire organism. ROS is composed of free radicals
and peroxides that are derived from oxygen metabolism and therefore inherently 
exist within all aerobic organisms. Due to unpaired electron(s), free radicals are 
highly unstable and can extract electron(s) from nearby molecules eliciting 
oxidative damage to DNA, lipids, and proteins which cause drastic cellular 
changes that can affect the entire organism (Beal 1995). Free radical production 
is ideally balanced by its consumption by antioxidants. Oxidative stress therefore 
occurs when the balance of antioxidants is outweighed by pro-oxidants (Seis 
1991).
2.3 Microglia
The microglia are the macrophages of the CNS and primary mediators of 
neuroinflammation. In a healthy brain, microglia dynamically sample their 
microenvironment through continual extension and retraction of their processes 
(Nimmerjahn et al. 2005, Raivich 2005). When activated, microglia transform 
their structure to fill functional protective and repair roles (Tansey et al. 2007, 
Tansey and Wyss-Coray 2008). These activated microglia now act as 
phagocytes that scavenge cellular debris, dying cells and neurotoxins. They also 
secrete trophic factors that promote neuronal survival and a variety of 
inflammatory mediators (cytokines: TNFa and interleukins IL-1B and IL-6; 
chemokines: macrophage inflammatory protein MIP-1a, monocyte chemo- 
attractant protein MCP-1, interferon IFN, and inducible protein IP-10) that 
promote the inflammatory state (Frank-Cannon et al. 2009, Schmidt et al. 2009).
8
In addition to environmental insults, genetic mutations may produce toxic 
proteins that unceasingly promote microglial activation and lead to aberrant 
responses to subsequent insults as illustrated in Fig 2.1 (Frank-Cannon et al.
2009). Neuroinflammation is the brain’s required response to clear cellular 
debris, limit tissue damage, and contribute to wound repair within the CNS. It is 
critical to distinguish the inflammatory factors and mechanisms that lead to 
neurotoxicity and death from the neuroprotective effects of microglia (Liu et al. 
2003).
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Fig 2.1 Neuroinflammatory Pathways may Lead to Neurodegeneration
Chronic neuroinflammation may lead to neuronal dysfunction and ultimately to 
neurodegeneration. A myriad of triggers transform microglia from the resting 
state to the amoeba-shaped activated macrophage form. Lectin proteins, stained 
by horseradish peroxidase (HRP), help illustrate the transformation of microglia 
in an injured rat cortex. The sustained production of neuroinflammatory 
mediators leads to a chronic self-propagating neuroinflammatory cycle. The 
continued demise of neurons creates cellular debris that causes microglia to 
remain in the activated macrophage state. Microglia photos were obtained from 
Wikipedia Commons, Mikroglejl_1 .jpg and Mikroglejl_2.jpg (Dec 2011). Content 
adapted from Frank-Cannon et al. 2009.
2.4 Inflammatory Cytokines
Tumor necrosis factor-alpha (TNFa) is secreted by glia cells in response 
to acute inflammation and infection. Deregulated production of TNFa results in 
chronic inflammation and sustained levels of ROS, hallmarks of many 
neurodegenerative diseases and cancer (Dowlati et al. 2010, Swardfager et al. 
2010. Locksley et al. 2001). Additionally, research at the Bowles Center for 
Alcohol Studies (University of North Carolina, Chapel Hill), has demonstrated 
increased TNFa production in response to ethanol at the cellular and systemic 
level, Fig 2.2, (Crews et al. 2006, Qin et al. 2008). TNFa activates two 
membrane bound enzymes (magnesium-dependent neutral sphingomeylinase 
and NADPH oxidase), which further compound oxidative stress (Li et al. 2009, 
Wheeler et al. 2009).
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Fig 2.2 Ethanol Exposure Increases Enzymatic Production of ROS
Membrane sphingomyelin is converted to ceramide upon activation of membrane 
bound nSMase. Ceramide production initiates subunit assembly of NOX in lipid 
rafts. NOX activation generates ROS.
Recent work in our laboratory has demonstrated the ability of ursolic acid, 
isolated from blueberries, to block the activation of neutral spingomeylinase 
(nSMase), and the functional assembly of NADPH oxidase (NOX) (Gustafson et 
al. 2012, in press). Therefore, it is feasible to propose that ursolic acid and other 
blueberry compounds may blunt oxidative stress induced by up-regulated TNFa 
production due to ethanol abuse. Easily administered dietary modifications that 
can blunt TNFa secretion may break the tragic cycle of inflammation that 
deteriorates the health of individuals suffering from a far reaching spectrum of 
disorders, including alcoholism.
2.5 Antioxidants in Blueberries
Antioxidants are substances namely found in fresh fruits and vegetables 
that scavenge and stabilize free radicals and thereby prevent oxidative damage. 
High levels of antioxidant anthocyanins are found in the skins of Alaskan 
blueberries which defend against light stress invoked by the long daylight hours 
encountered in high latitudes. Bioavailability studies of anthocyanins indicate 
that these highly pigmented compounds can localize in the brains of rats fed 
blueberries thus suggesting blood brain barrier (BBB) permeability (Andres- 
Lacueva et al. 2005). Studies also reveal that blueberries exhibit potent 
neuroprotective qualities that alleviate cognitive decline and even improve 
cognitive abilities and motor skills in the aging population (Joseph et al. 1999,
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Youdim et al. 2000, Lau et al. 2007). We believe supplementation of blueberries 
into the diet will potentially mitigate inflammatory stress.
2.6 Ursolic Acid and Oleanolic Acid
Our laboratory has demonstrated that ursolic acid isolated from the 
nonpolar lipophilic fraction of Wild Alaska Bog Blueberries blunts inflammatory 
stress induced by TNFa by stabilizing the integrity of lipid rafts and cytoskeletal 
organization within human neuroblastoma cells (Gustafson et al. 2012, prepared 
for submission). Ursolic Acid (UA) and its isomer, oleanolic acid (OA), are 
pentacyclic triterpenes (Fig 2.3) with demonstrated anti-inflammatory, 
hepatoprotective, anti-hyperglucemic, and anti-tumor protective capabilities 
(Brieskorn and Klinger 1961, Liu 1995, Schneider et al. 2009). Both UA and OA 
have identical molecular weights and differ only in the positioning of one methyl 
group (Schneider and Hosseiny 2009). The triterpenes found in fruits typically 
reside in the waxy outer protective layer of the skin (Orban and Kozak 2009).
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Fig 2.3 Chemical Structures of Ursolic and Oleanolic Acids
Ursolic acid and Oleanolic Acid are pentacylclic triterpene acids found in plants, 
particularly in many herbs, berries, and apple peels (de Queiroz et al. 2011). 
Structures were obtained from Wikipedia Commons Ursolic acid.png and 
Oleapolic acid.png (Dec 2011).
It is unknown whether the colorless blueberry fraction containing ursolic 
acid (UA), can definitively cross the BBB. Encouraging studies however 
demonstrate that UA, derived from natural products such as blueberries, can 
attenuate oxidative damage and ameliorate cognitive deficits in mice (Lu and 
Zheng 2007) and rats (Shih et al. 2004) against induced neurotoxicity. These 
results suggest that blueberry extracts and ursolic acid may offer novel 
therapeutic treatments against neurodegeneration caused and exacerbated by 
oxidative stress in individuals suffering from a myriad of neurodegenerative 
diseases.
Recent work with both UA and OA isolated from glossy privet fruit and 
hawthorn fruit has also revealed their capability to effectively suppress the 
formation of two glycative products (pentosidine and carboxymethyllysine -
CML), formed from reactive carbonyl compounds and proteins (Yin and Chan 
2007). It is well documented that these glycative products enhance the 
progression of glycation associated diseases such as Alzheimer’s disease (AD),
\  diabetes, atheroscolerosis, osteoarthritis, inflammatory arthritis, and cataracts 
(Monnier et al. 2005, Bar et al. 2003, Mera et al 2005, Reddy and Beyaz 2006). 
Since UA and OA may provide significant antiglycative and antioxidant 
protection, UA/OA supplementation may also delay progression of these 
diseases (Yin and Chan 2007).
2.7 Lipid Rafts
Lipid rafts are highly dynamic microdomains residing within fluid cellular 
plasma membranes (Fig 2.4). Their distinct and ordered lipid composition is 
essential for spatial and temporal signal modification between neurons (Simons 
and Toomre 2000, Harder and Engelhardt 2004). Well-ordered lipid raft 
platforms are rich in cholesterol and sphingolipids and found to provide 
scaffolding for signaling and redox events (Klopfenstein et al. 2002, Vilhardt and 
Van Deurs 2004, Yang and Rizzo 2007). Alterations to lipid raft composition 
may therefore alter lipid and protein interactions necessary for signaling 
molecules to functionally assemble.
Cholesterol depleting compounds, such as methyl-beta-cyclodextrin 
(MBCD), are shown to obliterate lipid raft formation (Gustafson et al. 2012, 
prepared for submission). Interestingly, preventive treatment with ursolic acid
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hinders the functional assembly of nSMase and NOX expected to form in lipid 
rafts due to TNFa insult. It is proposed that the structural similarity of UA (Fig 
2.3) to cholesterol (Fig 2.5) may allow UA to displace cholesterol and modulate 
lipid rafts (Gustafson et al. 2012, prepared for submission). Lipid rafts (Fig 2.4) 
now present as a therapeutic target to mitigate neuroinflammatory signaling 
events.
Fig 2.4 Lipid Raft Diagram
A. Intracellular space ' cytosol 
B Extracellular space
1. Non-raft plasma membrane (non-ordered and detergent soluble)
2. Lipid raft (ordered and detergent resistant)
3. Lipid raft associated transmembrane protein
4. Non-raft membrane protein
5. Glycosylation modifications (on glycoproteins and glycolipids)
6. GPI-anchored protein
7. Cholesterol
8. Glycolipid
Wikimedia Commons: Lipid Raft Organization scheme.SVG (Dec 2011)
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Cholesterol
Fig 2.5 Chemical Structure of Cholesterol
Cholesterol is integral to lipid raft structure (Fig 2.4).
Wikipedia Commons: Cholesterol.SVG (Dec 2011)
2.8 Voltage-Gated Sodium Ion (Nav) Channels
Sodium ion channels are embedded in lipid raft structures and are integral 
to the rapid electrical signaling process of excitable cells, and play a role in the 
molecular basis of tolerance (Pietrzykowski and Treistman 2008). Oxidative 
stress and ethanol exposure induce formation of large lipid raft signaling 
platforms that may elicit significant changes in the electrical potential of such 
cells (Dai et al. 2005). Instances of epileptic seizures, a disorder of sodium ion 
channel function, are increased in alcoholics (Frucht et al. 2000). Taken 
together, an important correlation between oxidative stress, lipid rafts, sodium ion 
channel function, and alcohol abuse needs to be elucidated.
Voltage gated sodium ion (Nav) channels are heteromeric membrane 
proteins composed of alpha and beta subunits with a molecular weight of about 
260 kDa (Goldin 2001). Ten isoforms of the Nav channel alpha subunit are 
encoded by ten different genes in mammals (Schaller and Caldwell 2003). The
large alpha subunit controls channel gating through four homologous domains 
which consist of the sodium ion conduction pore and the voltage sensor (Fig 2.6). 
This subunit exerts control over the sodium flux into the cell upon membrane 
depolarization and channel activation. The alpha subunit undergoes both 
glycosylation and phosphorylation during post-translational modification (Schaller 
and Caldwell 2003). The smaller auxiliary beta subunits then fine tune the 
voltage dependence and kinetics of the channel gating (Goetz et al. 2009). 
Intracellular protein interactions with Nav channels are essential for both function 
and proper subcellular location (Peles and Salzer 2000). Because sodium 
channel pathogenesis is involved in epilepsy, cardiac arrhythmias, neuropathy, 
multiple sclerosis, and cerebellar ataxia (SCA27), it is a very important target for 
drug therapy (Wittmack et al. 2004).
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G -  glycosylation 
P -  phosphorylation 
S -  ion selectivity 
I -  inactivation 
N -  amino terminus 
C -  carboxyl terminus
Fig 2.6 The Voltage-gated Sodium Ion (Nav) Channel
The four homologous transmembrane domains of the Nav channel alpha subunit 
are indicated (I -  IV). The domains associate in the membrane to form a Na+ 
permeable pore. The intercellular loop between domains III and IV forms the 
inactivation gate of the channel. The positive (+) charges in S4 provide a means 
to sense voltage and the S5-6 loop lines the channel pore.
Wikimedia Commons: sodiumchannel.svg (Dec 2011)
Expression of the alpha and beta subunits is tissue and cell specific. Four 
of the Nav alpha subunits (Nav1.1, 1.2, 1.3, and 1.6), are expressed in both the 
CNS and PNS; three are expressed in the PNS only (Navi .7, 1.8, and 1.9); and 
two are expressed in the muscle and heart (Navi .4 and 1.5). All three beta 
subunits (NaB1, 2, and 3) are expressed in the brain and heart, whereas only 
NaB1 and NaB2 are found in the muscle (Meisler and Kearney 2005).
2.9 Nav Channel Distribution in the Cerebellum
Four voltage gated sodium ion channels are expressed in the cerebellum. 
Navi .1. Navi .2, Navi .3 (development only), and Navi .6. These channels are all 
tetrodotoxin (TTX)-sensitive and are difficult to differentiate electrically; therefore
immunolocalization studies are most effective in determining their regional 
membrane and cellular distribution (Schaller and Caldwell 2003). A composite of 
immunochemical data is illustrated in Fig 2.7. Mature cerebellar Purkinje 
neurons predominately express Nav1.6 channels which enable sustained high 
frequency repetitive firing due to their generation of resurgent Nav current during 
action potential repolarization (Afshari et al. 2004, Raman et al. 1997). Navi .6 
labeling also reveals both presynaptic and postsynaptic membrane localization in 
the parallel fibers and the dendritic spines of Purkinje neurons (Caldwell et al. 
2000). The ability of Nav1.6 to reside in multiple locations suggests differential 
interaction with modulating proteins. Additionally, intracellular labeling of Navi .6 
is prominent in Purkinje dendrites indicating the possibility of pooled Navi .6 that 
can be quickly recruited to active synapses and play a role in synaptic plasticity 
(Caldwell et al. 2000). Nav 1.6 channels are also expressed in the cerebellar 
granule cells (parallel fibers) that communicate directly with Purkinje neurons. 
Labeled parasagittal sections of the rat brain reveal heavier labeling of Navi .6 in 
the granule cells of the posterior lobe opposed to those of the anterior (Schaller 
and Caldwell 2003).
Sodium channels, Nav1.1 and Nav1.2, have been found to be responsible 
for fast kinetics within the cerebellum. Navi .1 is found in Purkinje soma and 
dendrites, interneurons of the molecular layer, and within deep cerebellar 
neurons (Fig 2.7). Navi .2 is found in the unmyelinated granule cell axons and in 
the interneurons of the molecular layer (Fig 2.7) (Schaller and Caldwell 2003).
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Interestingly, the aging process has recently revealed a shift in expression of Nav 
channels in the cerebellum of aged rats. This study demonstrates an age related 
increase in Nav1.1 immunoreactivity in Purkinje cell bodies and a simultaneous 
decrease of Nav1.1 in granule cells. Additionally, in the cerebellar nuclei of aged 
rats, Nav1.1 and Nav1.2 expression was selectively increased in cerebellar 
output neurons. This research for age related changes in Nav channel 
expression of the cerebellum will help explain alterations in synaptic transmission 
during aging (Chung et al. 2003).
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Fig 2.7 Sodium Channel Distribution in the Cerebellum
Sodium channel distribution in the rat cerebellum was determined by 
immunolocalization studies and is color coordinated to represent Nav1.6 (red), 
Nav1.2 (green), and Nav1.1 (blue) in specific neuronal cells. It is unknown what 
isoforms of sodium ion channels are present in the cells illustrated in black. 
Adapted from (Schaller and Caldwell, 2003).
2.10 Ankyrin-G and Nav Channels in Purkinje Initial Segments
The axon initial segment (AIS) is an excitable membrane responsible for 
integrating neuronal inputs and initiating action potentials. The AIS is highly
enriched with Navi .6 channels in mature cerebellar Purkinje neurons. Ankyrin-G 
coordinates the physiological assembly and clustering of Nav1.6 channels, the 
BIV spectrin membrane skeleton, and transmembrane cell adhesion molecules 
(L1 CAM) in the AIS (Jenkins and Bennett 2001). Lack of ankyrin-G expression 
results in Purkinje neurons with abnormal sodium ion channel distribution and 
corresponding impaired ability to generate action potentials (Zhou et al. 1998). 
Mutations in either Navi .6 or ankyrin-G exon 1B both result in decreased 
Purkinje firing (Raman et al. 1997), impaired Purkinje action potential generation, 
Purkinje degeneration, and cerebellar ataxia (Dick et al. 1985, Kohrman et al. 
1996, Zhou et al. 1998). The ataxic phenotype exhibited in ankyrin-G knockout 
mice may be explained by loss of Navi .6 at the AIS (Jenkins and Bennett 2001).
2.11 Nav Distribution in the Dorsal Root Ganglias (DRGs)
As in other neurons, cytosolic proteins regulate the trafficking and function 
of the Nav channels in DRGs of the PNS. Navi .6 is highly expressed at the 
nodes of Ranvier and along the unmyelinated fibers of the PNS. One of the 
fibroblast growth factors, FGF13, is found to collocate with Nav1.6 channels in 
DRGs. Their association with Nav1.6 channels significantly increases peak 
amplitude thereby causing a depolarizing shift of voltage-dependent inactivation 
of the channel. Interestingly, FGF13 is not expressed in the ventral root motor 
axons. This preferential expression of FGF13 for the sensory neurons as 
opposed to the motor neurons may explain physiological differences reported in
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the sodium currents within the PNS (Wittmack et al. 2004). The axons of 
sensory neurons are more likely to fire repeatedly in response to continuous 
stimulus than those of motor neurons (Erlanger and Blair 1938). Sensory 
neurons are also sensitive to different injuries and neuropathies which may be 
indicative of both variable sodium channel expression and regulatory protein 
interaction (Wittmack et al. 2004). Through research on diabetic rats, evidence 
suggests that reduction of Navi .6 at the nodes of Ranvier in large DRGs leads to 
slowed nerve conduction velocity (Kearney et al. 2002) that contributes to 
diabetic sensory neuropathy (Hong and Wiley 2006). It is unknown whether 
neuroninflammation may promote sensory peripheral neuropathy through Nav 
channel dysfunction. This study will take the first steps to investigate this 
question by determining changes in Nav channel densities due to inflammation.
2.12 Nav1.6 and Resurgent Sodium Current in Purkinje and DRG Neurons
Resurgent sodium currents are produced by unusual gating behavior of 
TTX-sensitive Nav channels. Like other channels, upon depolarization, channels 
activate and inactivate, but a repolarizing current of only -50 to -60 mV causes a 
transient surge of sodium where other sodium channels would remain closed to 
recover from inactivation. Resurgent current equates to unusually rapid recovery 
from inactivation and priming of the channel to promote a second action potential 
(Raman and Bean 1997, Bean 2005). The high-frequency firing of Purkinje 
neurons is due to resurgent current.
The unique resurgent sodium current critical for determining the firing 
patterns of the cerebellar Purkinje neurons (Raman and Bean 1997) has also 
been recorded in native DRG neurons. Navi .6 is found to underlie the resurgent 
current generation in both Purkinje and DRG neurons (Cummins et al. 2005). 
Resurgent sodium current in Purkinje neurons is nearly obliterated in N avi.6-null 
mice (Raman et al. 1997). Minimal amounts of resurgent current are probably 
produced through Nav1.2 expression (Cummins et al. 2005). Importantly, 
although Navi .6 is present in both small and large DRG neurons, resurgent 
current is not observed in the small DRGs (Black et al. 2002). Differentially 
expressed factors involved in Nav1.6 function may determine the ability of this 
channel to generate resurgent currents (Cummins et al. 2005). Likewise, Navi .6 
is expressed in the hippocampus (Raman and Bean 1997) and spine (Pan and 
Beam 1999) without producing resurgent current. The role of sensory neuronal 
excitability due to the generation of resurgent sodium current by Navi .6 channels 
in DRGs begs further investigation.
2.13 Sodium Ion Channel Disorders
Sodium ion channel disorders are caused by a myriad of factors and 
intercellular proteins that influence channel function and timing. Another 
fibroblast growth factor, FGF14, differentially modulates interaction with several 
Nav-alpha (pore forming) subunits including Nav1.1, Nav1.2, Nav1.5 (heart), and 
Navi .6 (Lou et al. 2005). FGF14 is also collocated with Navi .6 and particularly
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enriched at the axonal initial segments which are critical for action potential 
generation and propagation in the CNS and PNS (Kaplan et al. 2001, Clark et al.
2005). Intriguingly, a mutation in the human SCN8A gene that encodes Navi .6 
was recently found to lead to cerebellar atrophy, ataxia, and mental retardation 
strikingly similar to individuals possessing a FGF14 mutation in spinocerebellar 
ataxia 27 (SCA27), (Trudeau et al. 2006). Clinical assessments of these patients 
and immunochemical data point to the unique function of Nav1.6 in the 
cerebellum.
A growing number of sodium ion channel mutations have been identified 
in other cases of neurological disease. Epilepsy results in almost 200 of these 
mutations and illustrates the particularly sensitivity of the nervous system to 
sodium ion channel aberrations. Persistent sodium current, deregulation, or loss 
of function may result in serious neurological disease. Symptoms of Nav channel 
dysfunction may include seizures, ataxia, paralysis, pain resistance, dystonia, 
learning deficits, and psychiatric disease (Meisler and Kearney 2005). The 
increased occurrence of seizures during acute alcohol intoxication and withdraw 
leads us to investigate ethanol’s influence on Nav channel dysfunction.
2.14 Cerebellum
Historic views of the cerebellum limit its function to the coordination of 
voluntary movement, gait, posture, speech, and motor function (Ghez and Fahn 
1985). Current studies however, reveal its role in higher cognition, behavior and
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psychiatric illness to include autism, schizophrenia, dementia, and alcohol 
dementia (Schmahmann 2004, Rapoport et al. 2000). Although not generally 
considered to be of cerebellar origin, Alzheimer's disease also causes a 
significant decline in the cerebellar Purkinje neurons (Rapoport et ai. 2000).
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Fig 2.8 The 1918 Sketch of the Cerebellum
Wikimedia Commons Gray706.png, Gray’s Anatomy 1918, accessed (Dec 2011).
Purkinje cells are the largest neurons in the brain and are easily identified 
by their elaborate dendritic arbors (Fig 2.8). Each dendritic tree interacts with 
nearly 200,000 parallel fibers that form 500 granule-Purkinje cell synapses per 
climbing fiber. Purkinje cells also receive inhibitory GABA inputs from basket 
cells (at axon initial segments) and stellate cells (on the dendrites), Fig 2.7. The 
Purkinje coordinates all these inputs and produces the sole inhibitory output of 
the cerebellar cortex to the deep cerebellar nuclei (Wadiche and Jahr 2001,
Tyrrell and Willshaw 1992). Purkinje dysfunction is therefore catastrophic to the 
cerebellum which houses half the brain’s neurons and orchestrates inputs from 
all over the brain (Rapoport et al. 2000). Consequently, its influence on functions 
held primarily in other regions is very likely.
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Fig 2.9 The Cerebellum and Surrounding Regions
The regions include: A) midbrain, B) pons, C) medulla, D) spinal cord, E) fourth 
ventricle, F) arbor vitae, G) tonsil, H) anterior lobe, I) posterior lobe.
Figure from Wikimedia Commons: CerebellumRegions.jpg (Dec 2011).
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Fig 2.10 Major Subdivisions of the Cerebellum
The diagram illustrates the cerebellum from the superior view when laid out two 
dimensionally. Wikimedia Commons: CerebellumDiv.png (Dec 2011)
Imaging studies of the alcoholic brain reveal obvious cerebellar atrophy, 
particularly in the anterior lobe and vermis (Sullivan et al. 2006). This pattern 
mimics the atrophy observed in individuals with degenerative cerebellar ataxia 
suggesting common pathways or vulnerabilities (Schmahmann and Caplan 
2006). The proposed study will specifically determine how the cerebellum is 
affected by alcohol abuse and its correlation to observable changes in behavior 
and motor performance. We believe supplementation with blueberries will 
drastically mitigate inflammatory stress and prevent neurodegeneration due to 
alcoholism and other chronic conditions marked by increased oxidative stress.
Chapter 3: Alcohol Abuse Triggers Dynamic Alterations in Neuronal 
Membranes via Oxidative Stress
3.1 Alcohol and Inflammation
Alcohol consumption is common to people groups worldwide. Although 
moderate intake may provide some health benefits, excess consumption leads to 
systemic inflammation and increased morbidity (Vasdev et al. 2006). On the 
cellular level, alcohol abuse is marked by oxidative stress and lipid peroxidation 
of cellular membranes (Nordmann et al. 1990a&b). Lipid peroxidation reduces 
membrane bilayer fluidity and potential, thereby altering lipid raft formation and 
subsequent signaling and synaptic events (Szabo et al. 2007). Additionally, 
ethanol dramatically suppresses immunological and antioxidant defense systems 
thus amplifying the delirious effects of free radicals and creating a continued 
cycle of oxidative stress (Szabo 1997, Wilson 1997, Dringen et al. 2000). 
Collectively, this cascade of events may lead to cellular dysfunction and death. 
Interventions that block this chronic inflammatory response provide potential 
therapeutic avenues for limiting the impact of oxidative stress in cases of alcohol 
abuse and other inflammatory and degenerative diseases. Although, alcohol 
exerts its affects through a myriad of mechanisms and produces a wide spectrum 
of responses throughout the body, this chapter will focus primarily on the 
pathways that ultimately lead to impaired brain function through altered 
membrane dynamics and oxidative stress.
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3.2 Ethanol’s Path through the Body
To examine the effects of alcohol on the brain we must first review the 
path it takes to get there. Upon consumption, ethanol is minimally metabolized in 
the stomach and quickly absorbed through the gastrointestinal (Gl) tract.
Chronic alcohol consumption leads to a breakdown of the Gl mucosal barrier 
whereby resident microbes may enter into the bloodstream. Lipopolysaccharide 
(LPS), a potent endotoxin making up gram-negative bacteria cell walls, is 
therefore frequently elevated in alcoholics due to their ’leaky guts’. Once LPS 
enters the bloodstream, it stimulates activation of leukocytes through ligand 
binding to membrane associated toll like receptors (TLRs) that recognize 
pathogen-associated molecular patterns. Interaction with CD14, a 
glycosylphosphatidylinositol (GPI) linked protein, then amplifies TLR4 signaling 
through complex clustering and co-localization within lipid rafts. At 
physiologically relevant doses of ethanol (10-50mM equivalent to 0.05-0.24 blood 
alcohol content), ethanol mimics LPS in TLR4 complex assembly and 
concurrently triggers downstream signaling pathways of NF-kB and mitogen- 
activated protein kinase (MAPK) to up-regulate expression of inflammatory 
cytokines, such as TNFa, IL-1B, IL10, and NO in the blood stream (Femandez- 
Lizarbe et al. 2007).
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3.3 Ethanol and Lipid Rafts
Strikingly, at high doses of ethanol (greater than 50mM as seen in 
extreme binge drinking), ethanol inhibits TLR activation by disrupting lipid raft 
formation. It is dear that ethanol can differentially affect the formation of lipid 
rafts and TLR activation dependent on its concentration. Furthermore, recent 
studies indicate that recruitment of various receptor molecules to lipid rafts via 
actin polymerization can be inhibited by ethanol (Szabo et al. 2007). Activation 
of TLRs is necessary to clear pathogens but must be tightly regulated in both 
intensity and duration in order to prevent chronic inflammatory states. 
Deregulation of the immune system contributes to the pathogenesis of 
inflammatory diseases common in alcoholics: liver disease, arteriosclerosis, 
arthrosclerosis, diabetes, irritable bowel syndrome, neuropathy, 
neuroinflammation and degeneration. Additionally, a strong correlation exists 
between alcohol consumption and the risk of infections such as pneumonia, 
tuberculosis, ARDS, Hepatitis-C, HIV, and HIV-dementia (Szabo 1997). The 
cycle of endothelial breakdown, pathogen entry, immune response, cytokine 
release, inflammation and oxidative stress is common throughout the body, to 
include the central nervous system (CNS).
3.4 Ethanol -  the Liver and Beyond
Kupffer cells, the specialized resident endothelial macrophages of the 
liver, produce a significant proportion of the TNFa found in the serum, which in
turn propagates the production of more TNFa in other tissues. Chronic ethanol 
feeding studies on rats demonstrate how ethanol exaggerates the LPS 
stimulated release of inflammatory cytokines in the liver and further generates 
reactive oxygen species (ROS) through assembly and activation of the lipid raft 
associated complex NADPH oxidase, (NOX) (Han et al. 2008, Thakur et al.
2006). Ethanol and ROS work in concert to hyper-sensitize Kupffer cells to LPS, 
hence amplifying the inflammatory response and increasing oxidative stress 
beyond the bounds of the liver.
3.5 Ethanol Metabolism
The liver handles the primary responsibility of metabolizing ethanol but 
can only do so at a rate of 0.25 ounces per hour. Alcohol ingested in excess of 
this rate will therefore be metabolized by other cells in the body. Ethanol is 
metabolized through two different processes dependent on its concentration (see 
Fig 3.1). These pathways hold the key to whether alcohol is beneficial to health 
by providing an anti-inflammatory environment or detrimental by increasing 
oxidative stress. At low doses, ethanol is metabolized by alcohol dehydrogenase 
to acetaldehyde and then by aldehyde dehydrogenase to acetate, where NADH 
is produced in both reactions. NADH is part of the electron transport chain and 
possesses a high reducing potential that regenerates vitamin radicals back to 
their reduced forms, thereby increasing antioxidant capacity (see Fig 3.2). 
Conversely, at high doses, ethanol is metabolized to toxic acetaldehyde by
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producing NADP+ which creates an oxidative environment and reduces 
antioxidant capacity (Vasdev et al. 2006).
Alcohol intake
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Fig 3.1 Differential Ethanol Metabolism
Adapted from (Vasdev et al. 2006).
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Fig 3.2 Low Ethanol Concentrations Reduce Vitamin Radicals
Adapted from (Vasdev et al 2006).
3.6 Astrocytes and the Blood Brain Barrier
The brain holds a privileged position in the body and is highly protected by
the blood brain barrier (BBB), but as with the other endothelial linings of the 
body, it too is disrupted by inflammation induced by alcohol (Weiss et al. 2009 
Haorah et al. 2007, Haorah et al. 2005a). The BBB is created by tight junctions 
(TJ) of endothelial cells within vessels of the brain that are then completely 
surrounded by astrocytes as seen in Fig 3.3. This unique arrangement restricts 
entrance through the BBB by tightly controlling permeability to plasmatic 
compounds and ions.
Cross section of brain capillary
a. Astrocyte Foot Processes
b. Basement Membrane
c. Endothelial Cell
d. Tight Junction (TJ)
e. Capillary Lumen
f. Astrocytes
g. Red Blood Cell (RBC)
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Fig 3.3 Astrocytes are Integral to the Blood Brain Barrier (BBB)
3.7 Blood Brain Barrier Transmigration
Increased levels of serum inflammatory cytokines dramatically alter the 
expression of surface adhesion molecules in leukocytes and CNS vascular 
endothelial cells. Mediation of adhesion molecules in leukocyte-endothelial cell 
interactions leads to ROS generation and TJ disruptions (Haorah et al. 2005a). 
Circulating leukocytes can now transmigrate through the BBB by way of these 
adhesion molecule interactions, a discovery that challenges the former concept 
of the brain as an immune privileged organ (Weiss et al. 2009). Upon entry into 
the brain, leukocytes stimulate a resident immune response from microglia which 
then initiates brain specific inflammation. Additionally, brain microvascular 
endothelial cells (BMVEC), can metabolize alcohol into acetaldehyde (AA) and 
activate myosin light chain kinases (MLCK) to phosphorylate MLC/TJ proteins 
which alter cytoskeletons, TJ integrity, and promote monocyte transmigration. 
Laboratory treatments of BMVEC with antioxidants has been shown to prevent 
BBB leakiness and underscores the role of oxidative stress in BBB impairment 
common to alcoholism and other neuroinflammatory diseases (Haorah et al. 
2005a&b). Generally however, steroids have been the only prescribed treatment 
option used to improve BBB integrity. Therapies targeting the inhibition of 
inflammatory cytokines and adhesion molecules present other potential 
approaches to mitigate BBB breakdown (Stamatovic et al. 2008).
Circulating serum inflammatory cytokines, such as TNFa and IL-1, quickly 
cross the BBB but appear to have a significantly longer lasting presence in the
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brain than in the liver or bloodstream. Excessive alcohol intake, even 
sporadically, produces continued up-regulation of inflammatory stressors in the 
brain that may last over a week. The sustained presence of cytokines further up- 
regulates membrane enzyme NADPH oxidase (NOX) which results in increased 
ROS production perpetuating the cycle of oxidative stress (Crews et al. 2006, 
Thakur et al. 2006).
3.8 Glial Activation due to Inflammation
A hallmark of neuroinflammation in the brain is glial cell activation, 
particularly that of microglia and astrocytes (Blanco et al. 2006). Glia cells 
undergo morphological changes and proliferate in response to alcohol induced 
brain damage as determined by post-mortem analysis on alcoholic brains (Crews 
and Nixon 2009). It has also been observed that cerebellar microglia 
proliferation precedes ethanol-induced atrophy of the anterior vermis of the 
cerebellum, most noted for degeneration in chronic alcoholics (Riikonen et al. 
2002). Glia also produce a variety of inflammatory cytokines that when left 
unchecked induce chronic inflammation and sustained levels of reactive oxygen 
species (ROS) common to neurodegenerative diseases and cancer (Dowlati et 
al. 2010, Swardfager et al. 2010, Locksley et al. 2001). Up-regulation of 
inflammatory mediators by alcohol triggers downstream activation of NF-kB and 
further amplification and sustainment of inflammation through inducible nitric 
oxide synthase (iNOS), IL-1 B, TNFa, and COX-2. Contrary to the fore-stated
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neurotoxic pathway, astrocytes are also programed to provide trophic and 
metabolic support to neurons by supporting axonal regrowth and enhancing the 
antioxidant environment (Valles et al. 2004).
3.9 Alcohol Impairs Antioxidant Defense of Astrocytes
Under intense oxidative stress, astrocytes become functional impaired and 
lose their ability to fulfill their protective role to neurons, leaving both cell types 
more vulnerable to dysfunction and eventual death (Valles et al. 2004). The 
human brain utilizes a disproportionate 20% of the body’s oxygen intake. 
Metabolism of oxygen produces a continual level of ROS whereby the brain must 
defend against the toxic effects of ROS. This role is primarily filled by the 
astrocytes which provide antioxidant glutathione precursors and reduced vitamin 
C to the neurons (Dringen et al. 2000, Wilson 1997). Alcohol may compromise 
the astroglial glutathione system that is integral to the brain’s defense against 
ROS.
3.10 Lipid Peroxidation
The brain’s cellular membranes contain a very high proportion of 
polyunsaturated fatty acids, which are greatly susceptible to lipid peroxidation 
induced through oxidative stress. Lipid peroxidation is a chain of events 
mediated by free radicals that leads to membrane deterioration. Alcohol abuse 
enhances lipid peroxidation, particularly in the cerebellum. Ethanol has also
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been shown to reduce antioxidant defenses, not only in the astroglial glutathione 
system, but also in neuronal superoxide dismutase (SOD), alpha-tocopherol 
(vitamin E), ascorbate (ester of vitamin C), and selenium (Nordmann et al.
1990a&b). Interestingly, the cerebellum shows the lowest concentration of a- 
tocopherol (Meydani et al.1986) in the brain and is particularly sensitive to its 
deficiencies (Le Bel et al.1989). Injury to the cellular membranes leads to 
decreased fluidity, modification of synaptosomes, and alterations of 
neurotransmitter metabolism, all of which could contribute to tolerance and 
dependence on alcohol (Zaleska et al. 1989, Nordmann et al. 1990a&b).
3.11 Tolerance and Alterations to Cellular Membranes
The disordering effect of ethanol in vitro is overcome by increases in 
cholesterol in vivo, providing a possible molecular basis of alcohol tolerance (Sun 
and Sun 1985, Pietrzykowski and Treistman 2008). Behavioral tolerance to the 
effects of alcohol entails complicated molecular processes that buffer the impact 
of acute alcohol intoxication. That being said, neuronal membrane-bound ion 
channels present a common mode of action for these interrelated pathways 
(Pietrzykowski and Treistman 2008). Numerous studies have sought to better 
understand the elusive molecular mechanism of ethanol-channel interactions in 
voltage gated sodium and potassium channels, chloride and calcium channels, 
acetylcholine, NMDA-glutamate, and GABA(A) systems (Peoples and Weight 
1997). Alterations in channel structure and function are imparted by the
membrane lipid microenvironment, direct protein interactions, gene transcription 
and epigenetics, all of which have been shown to be influenced by alcohol abuse 
(Pietrzykowski and Treistman 2008).
3.12 Omega-3-Fatty Acids in Neuronal Plasma Membranes
In addition to increases in cholesterol content, chronic alcohol abuse alters 
the composition of neuronal membranes by reducing unsaturated phospholipids 
(Chin et al. 1978), particularly the highly unsaturated omega-3 fatty acid, 
docosahexaenoic (DHA) (Pawlosky et al. 2001). Interestingly, ethanol increases 
incorporation of the membrane phospholipid, phosphatideylethanol (PE), but 
decreases its preferential association with DHA. Reduced DHA levels are also 
found in behavioral disorders and visual impairments associated with alcoholism, 
such as depression and retinal degenerative disease (Hibbeln and Salem 1995, 
Opreaunu et al. 2010, Ranjekar et al. 2003). In the healthy brain, DHA 
comprises approximately 50% of the phospholipid acyl chains with even greater 
concentrations in the synaptosomes. The hippocampus, critical for its role in 
learning and memory, is particularly sensitive to these alterations. Hippocampal 
dysfunction is clearly observed in cases of fetal alcohol syndrome and alcoholism 
(Cazzaniga et al. 2010, Gil-Mohapel et al. 2010).
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3.13 Dietary Therapies
Overwhelming evidence has shown that alcohol abuse promotes chronic 
neuroinflammation which induces oxidative stress, immune system impairment, 
and compromised neuronal health. Because continued oxidative stress can 
ultimately end in neurodegeneration and altered brain function, therapeutic 
interventions are imperative. Along with behavioral modifications, dietary 
changes offer the quickest and most affordable means to improve overall health 
and specifically combat oxidative stress. Antioxidants are naturally enriched in 
fruits, vegetables, and tea due to their flavonoid content. Many of these 
compounds have proven to be effective in inhibiting oxidative stress and lipid 
peroxidation specific to alcohol consumption. One such example is the grape. 
Grape skins are rich in many polyphenols to include resveratrol, quercetin, 
catechin, and proanthocanindins. Enrichment of grape extracts into chronic 
ethanol fed rats protected neurons by inhibiting ROS generation and lipid 
peroxidation, protecting against excitotoxic insult, restoring dopamine uptake, 
and by preventing calcium influx and depletion of glutathione. Additionally, this 
study clearly showed grapes to reverse the up-regulation of cyclooxygenase 
(COX-2) that ethanol intake had induced in yet another ethanol mediated 
mechanism yielding oxidative stress in the brain (Sun et al. 2002). Other fruits, 
such as blueberries, have also exhibited potent neuroprotective qualities that 
alleviate cognitive decline and even improve cognitive abilities and motor skills in 
the aging population (Joseph et al. 1999, Youdim et al. 2000, Youdim et al. 2002,
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Lau et al. 2007). Moreover, diets rich in fruits and vegetables induce epigenetic 
changes that further inhibit the expression of inflammatory genes (Szic et al.
2010) that are up-regulated through alcohol abuse.
3.14 Membrane Fluidity and DHA
Along with oxidative stress, alterations in the lipid composition of the 
plasma membrane pose additional challenges to overall neuronal health. 
Membrane fluidity is critical to proper synapse function where highly disordered 
regions rich in DHA allow for optimal vesicular neurotransmitter release (Stillwell 
et al. 2006). Additionally, DHA is a key factor in proper fetal brain development 
and continued neural growth as it crosses through the placenta and later into 
breast milk. To review, alcohol intake increases cholesterol and reduces DHA 
incorporation into the membranes, causing a stiffening effect. Studies now 
reveal that dietary DHA supplementation completely reverses this event by 
lowing cholesterol levels and increasing the concentration of DHA into the 
membranes (Stillwell et al. 2005). DHA is easily obtained through a diet rich in 
fish, particularly fatty fish like salmon, or through over-the-counter fish oil 
supplements. Further research in human endothelial retinal cells (HERC) has 
demonstrated DHA’s capacity to inhibit cytokine induced sphingomeylinase 
activity and further downstream NF-kB activation. Blunting the up-regulation of 
inflammatory genes like cellular adhesion molecules (CAMs) prevents 
inflammation induced by leukocyte migration into the retina through the retinal
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blood barrier (Opreanu et al. 2010). A similar response to DHA likely occurs in 
the brain at the BBB. Taken together, DHA supplementation provides another 
effective means to alleviate oxidative stress and improve neuronal health and 
brain function in instances of alcohol abuse.
3.15 Conclusions
In conclusion, alcohol abuse produces devastating effects on the brain 
through the ramifications of neuroinflammation and oxidative stress on cellular 
membranes. Oxidative stress is compounded by BBB breakdown, deregulation 
of the immune system, depression of the innate antioxidant defense system, and 
a sustained presence of inflammatory stressors in the brain. Neuronal 
membranes deteriorate in response to lipid peroxidation and impart drastic 
alterations in lipid composition. These changes suppress synapse function and 
thus lead to lasting behavioral, cognitive, and motor impairments in alcoholics. 
Fortunately, natural compounds easily accessible in the diet have been found to 
counteract the neuroinflammation and oxidative stress induced by alcohol abuse. 
Easily instituted dietary modifications may break the tragic cycle of inflammation 
and reverse the long term health impact of alcohol abuse in at risk individuals 
and developing babies subject to maternal alcohol abuse.
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Chapter 4: Materials and Methods
4.1 Materials
BCA Protein assay kit 
Cell Proliferation Kit (MTT)
Chicken TNFa assay kit 
DMEM powder 
F-12 powder 
FBS
Fertilized chicken eggs 
Fluorescent mounting media 
GFAP Ab-6 (mouse) for astrocytes 
GlutaMAX-1 
HBSS
Hoechst dye 33258 dye for dsDNA 
Laminin, murine EHS sarcoma 
Lipid Peroxidation assay kit 
Monoclonal mouse anti-Calbindin-D-28K ab 
Monoclonal mouse anti-SCN8A, Navi .6 ab 
Nerve Growth Factor 7S (mouse) 
Neurofilament (mouse anti-NF-M) 
Penicillin/Streptomycin 
Rabbit anti-Nav-pan ab
Pierce Biotech (Rockford, IL) 
Roche (Mannheim, Germany) 
Cusabio Biotech (Donghu, China) 
Mediatech (Herndon, VA) 
Sigma-Aldrich (St. Louis, MO) 
Gibco (Grand Island, NY)
Holly Halvarson (North Pole, AK) 
KPL (Gaithersburg, MD)
Thermo Scientific (Fremont, CA) 
Invitrogen (Carlsbad, CA) 
Sigma-Aldrich (St. Louis, MO) 
Invitrogen (Camarillo, CA) 
Trevigen (Gaithersburg, MD) 
Oxford Biomed (Oxford, Ml) 
Sigma-Aldrich (St. Louis, MO) 
Abnova (Taipei, Taiwan)
Enzo Life Sci (Plymouth Meeting, PA) 
Invitrogen (Camarillo, CA) 
Mediatech (Herndon, VA)
Assay Biotech (Sunnyvale, CA)
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Recombinant human TNFa ProSpec (Ness-Ziona, Israel)
ROS Detection Kit Molecular Probes (Eugene, OR)
Secondary antibodies Santa Cruz Biotech (Santa Cruz, CA)
Total Antioxidant Power assay kit Oxford Biomed (Oxford, Ml)
Trypsin/EDTA Invitrogen (Carlsbad, CA)
Vibrant Lipid Raft labeling kit Molecular Probes (Eugene, OR)
All other reagants Sigma-Aldrich (St. Louis, MO)
4.2 Blueberry Extract Preparation
Wild Alaska Bog Blueberries were collected from locations within interior 
Alaska and stored at -20 C. Berries were lyophilized and crushed to powder. 
Samples (-20 g) were fractionated over a silica column in 500 ml segments with 
a mobile phase of 80/20 dichloromethane/methanol. Extracts were filtered, roto- 
vaporized at 40°C to remove volatile organics, frozen and then lyophilized again. 
The powder extracts were stored at -20 C until reconstituted immediately prior to 
use in a 70/30-acetone/water solution, and diluted 1:20 into deionized (18 mega 
Q) water to produce non-polar and polar blueberry stock. Fractions were further 
separated into isolated compounds which produced the ursolic acid used in this 
thesis work. Blueberry extract preparations and fractionations were performed 
by Colin McGill of University of Alaska, Fairbanks, during his thesis work, 2010.
4.3 Chick Embryo Incubation
Fertilized Buff Orpington chicken eggs were purchased from a local 
supplier in North Pole, Alaska. Eggs were incubated at 37 degrees Celsius in a 
humidified egg incubator for 10 days to obtain neuronal samples from the 
forebrain, cerebellum, spine, DRGs, and olfactory bulb. Eggs were incubated for 
15 or 18 days to obtain additional cerebellar glia samples. Eggs were not 
washed before incubation to prevent disruption of the permeable membrane and 
transfer of microbes to the chick.
4.4 Chick Embryo Dissection
4.4.1 Brain
Embryonic chick neurological tissue was dissected from chicks at 
embryonic day-10 (ED10), ED15, and ED18 under a dissection microscope in a 
laminar flow hood. Chicken eggs were washed with soap and water, dried, and 
sprayed with 70% ethanol. Using sterilized forceps, the top of the egg shell was 
removed and the chick was extracted and placed into a sterilized glass dissection 
dish filled with iced HBSS fortified with 1% penicillin-streptomycin (PS). The 
neck was quickly and completely severed. The head and bodies were rinsed 
with hanks buffered saline solution (HBSS) and placed separate dishes filled with 
HBSS/1 % PS. Brains were dissected by carefully removing skin, the skull cap, 
and all surrounding meninges. Different sections of the brain were then 
dissected out and placed in new dishes with HBSS/1 % PS. All dishes containing
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dissected tissue were placed on ice. This process was repeated for additional 
eggs. Generally, 12 eggs were dissected at a time. The forebrain, cerebellum, 
olfactory bulb, spine and DRGs were identified utilizing The Atlas of Chick 
Development (Bellairs and Osmond 2005).
4.4.1.1 Forebrain
Forebrains were dissected from ED10 chicks as detailed in section 4.4.1. 
The two lobes of the forebrain were identified, dissected, and held on ice until all 
brain sections and spinal/DRG samples were collected from all eggs. The 
tissues were then collectively triturated by section and dissociated as detailed in 
4.5.1.
4.4.1.2 Cerebellum
Dissections of the cerebellum occurred at ED10 (neuronal cultures), ED15 
(glial cultures), and ED18 (glial cultures used to produce glial conditioned media). 
Using the same general dissection procedure, the cerebellum was removed from 
the hindbrain. Great care was taken to cut through thicker skin and connective 
tissue covering ED10 cerebella. Later at ED15 and ED18, the formation of the 
skull was significantly more advanced and was carefully removed to expose the 
brain.
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The olfactory bulbs (OB) were dissected at ED10. The two OBs were 
somewhat difficult to identify and are located on the anterior/inferior side of the 
two lobes of the forebrain. Careful examination revealed the olfactory nerve 
running from the OB to the nasal cavity of the beak. Using the same dissection 
techniques, OBs were removed without the connecting nerve.
4.4.2 Spine
After all the brain tissue was dissected from ED10 chicks, the spine and 
DRGs were dissected from the bodies that were still held on ice. We laid each 
body supine in a new sterilized dish filled with fresh iced HBSS/1 % PS. The 
chest cavity was opened and organs removed until the spinal column was 
exposed. The connective tissue surrounding the spinal column was carefully 
removed to expose the spine and DRGs. The spine was dissected out, 
meninges removed, and placed on ice in a new dish containing HBSS/1 % PS.
4.4.3 DRGs
After the spine was dissected out, DRGs were individually extracted. The 
nerve connected to each DRG was removed and the meninges were separated 
off. The cleaned DRG was placed on ice in a separate dish containing HBSS/1 % 
PS.
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4.4.1.3 Olfactory Bulbs
4.5.1 Cell Culture - Neurons
Neurons were dissociated from dissected forebrain, cerebellum, spine, 
DRG, and olfactory bulb tissue of ED 10 chicks. Dissociation began by incubating 
neurological tissues in 0.025% trypsin/EDTA and 1% penicillin/streptomycin (PS) 
solutions of HBSS for 20 minutes, followed by 10 minutes of trituration through 
glass pipets. Suspended tissue was then spun down, pelletized, and re­
suspended in plating media. Dissociated neurons were cultured on falcon dishes 
first coated with 10 ug/ml poly-D-lysine in borate buffer and then 1 mg/ml laminin 
in F-12. The media contained high glucose DMEM supplemented with 10% fetal 
bovine serum (FBS), 3.7 g/L sodium bicarbonate, 1% PS, 1% GlutaMax-1 (GM), 
1% N3, and 1% 5-fluorodeoxyuridine (FdUr) mitosis inhibitor in F-12. Nerve 
growth factor, 20 ng/ml, was added to media for DRG and olfactory bulb (OB) 
cultures. Cerebellar neuron cultures were also supplemented with 5% astrocyte 
conditioned media. Cultures were incubated in 5% C02 at 37 C. After 24 hours, 
cultures were rinsed with HBSS and replenished with fresh media. After one 
week in culture, media was replaced with serum free media supplemented as 
detailed above with the exception of 5 mg/ml bovine serum albumin (BSA) in 
place of FBS. All experiments were run 24-hours after serum depriving the 
neuron cultures.
4.5 Cell Culture
Glia cells were dissociated from dissected cerebellums of ED-15 and ED- 
18 chicks by first incubating the cerebellum in 0.025% trypsin/EDTA and 1% 
penicillin/streptomycin (PS) solutions of HBSS for 20 minutes, followed by 10 
minutes of trituration through a glass pipet. Suspended tissue was then spun 
down, pelletized, and re-suspended in plating media. Glia cultures were grown in 
DMEM medium supplemented with 10% FBS, 3.7 g/L sodium bicarbonate, 1%
PS and1% GM. Every two days, media was removed. Media removed from 
ED18 glia cultures was further filtered through 0.2 micron polyethersulfone (PES) 
membrane filters to collect astrocyte conditioned media used to supplement 
cerebellar neuron cultures. Glia cultures were rinsed with HBSS and replenished 
with fresh media. After one week in culture, ED15 media was replaced with 
serum free media supplemented as detailed above with the exception of 5 mg/ml 
BSA in place of FBS and the addition of FdUr mitosis inhibitor to prevent further 
cell division. All experiments were run 24-hours after serum depriving the ED15 
neuron cultures. ED18 cultures were used for the sole purpose of producing 
astrocyte conditioned media for cerebellar neuron cultures.
4.6 Cell Viability
4.6.1 Cell Viability - Light Microscopy of Neurons and Glia
After growing cells in culture for one week, neurons and glia cells were 
observed under the Nikon Eclipse TE 2000U inverted microscope to give a visual
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4.5.2 Cell Culture -  Glia
assessment of health. Only cultures free of microbial contamination were used 
for further experimentation. Cultures free from microbes were held under serum 
free conditions for 24 hours and then treated with 200ng/ml TNFa, E17, E35, or 
E100 to evaluate the toxic effects of TNFa and ethanol on neurite outgrowth, 
membrane blebbing, and cell death. Cells were also supplemented with 5ug/ml 
blueberry extracts (BBX, NP, and UA) to likewise assess viability. Pre- and post­
treatments of these extracts were used to visualize the effects of blueberry 
supplementation on the neurons and glia cultured with TNFa or ethanol.
4.6.2 Cell Viability -  MTT Assay
Neurons were cultured on 96-well clear falcon plates coated with poly-D- 
lysine and laminin for one week and then serum deprived overnight prior to 
experimentation. Metabolic cell viability was assessed using an MTT assay as 
per manufacturer’s instructions (Roche). Formazan generation was measured by 
absorbance (595nm -  620nm) using a Beckman Coulter Multimode DTX 880 
multi-plate reader. Protein content was determined for each sample using the 
BCA protein assay kit (Pierce) and used to calculate absorbance per whole cell 
protein content.
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ROS was quantified as DCF-fluorescence produced from the oxidation of 
H2DCFDA to DCF by peroxide. Neurons were cultured on 6-well clear falcon 
plates coated with poly-D-lysine and laminin for one week and then serum 
deprived overnight prior to experimentation. Immediate ROS generation assays 
determine ROS produced after 45 minutes of pretreatment and 45 additional 
minutes of post-treatment. Longer term ROS generation was determined by 
pretreating cultures for 24 hours and post-treating for an additional 24 hours.
4.7.1 Immediate ROS Generation
Pretreatments were applied for 45 minutes in conjunction with 10uM 
H2DCFDA in SF media. After 45 minutes, cell cultures were washed with HBSS 
and allowed to rest in SF media for 30 minutes in cell culture incubator. Cells 
were then lysed with 2% SDS, scraped with a cell scraper, homogenized, and 
transferred to a 96-well black Falcon plate in 100ul samples. A BCA protein 
assay was run on each sample to determine whole cell protein content.
Formation of ROS was quantified as DCF-fluorescence intensity read by a 
Beckman-Coulter Multimode DTX 880 microplate reader using 495 nm excitation 
and 525 nm emission filters. ROS generation was also determined at the 
completion of pre- and post-treatments. Cells were pretreated for 45 minutes, 
rinsed with HBSS, and post-treated in conjunction with 10uM H2DCFDA in SF 
media. Cells were rested, lysed, scraped, and transferred for protein assays and
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4.7 ROS Detection
DCF-fluorescence assays as previously described. Data was compiled in graphs 
to compare ROS generation after 45 minutes (pretreatments) and after 90 
minutes (pre- + post-treatments).
4.7.2 Long Term ROS Generation
Pretreatments were applied for 24 hours and followed by media removal, 
rinsing with HBSS, and 24 hours of post-treatment. After 24 hours of post­
treatments, cultures were rinsed with HBSS and loaded with 10uM H2DCFDA in 
SF media for 45 minutes. Cell cultures were then washed with HBSS and 
allowed to rest in SF media for 30 minutes in cell culture incubator. Cells were 
then lysed with 2% SDS, scraped with a cell scraper, homogenized, and 
transferred to a 96-well black falcon plate in 100ul samples. A BCA protein 
assay was run on each sample to determine whole cell protein content.
Formation of ROS was quantified as DCF-fluorescence intensity read by a 
Beckman-Coulter Multimode DTX 880 microplate reader using 495 nm excitation 
and 525 nm emission filters.
4.8 Total Antioxidant Power Assay
Total antioxidant capacity of both cellular and treatment samples was 
determined by quantifying their reduction potential to convert Cu+2 to Cu+1. The 
copper reduction potential is expressed in calibrated Trolox equivalents. Higher 
levels of Trolox indicate higher total antioxidant power and protection from
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oxidation. The colorimetric measurement of optical density was read at 450nm 
using a Beckman-Coulter Multimode DTX 880 microplate. A BCA protein assay 
was run on cellular samples to determine Trolox equivalent per ug of whole cell 
protein. The Oxford Biomedical antioxidant power kit provides procedures for 
cell culture and liquid food samples. Antioxidant assays were performed for 
treatments (untreated media, diluents, BBX, NP, P, UA, and E35), cells (C, Cb,
S, DRG, OB, and G), and treated cells (Cb, DRG, and G).
4.9 Lipid Peroxidation Assay
Lipid peroxidation is an indicator of cellular injury due to oxidative stress. 
The lipid peroxidation assay quantifies compounds (malondialdehyde -  MDA and 
4-hydroxyalkenals -  HAE) that are produced from the decomposition of unstable 
lipid peroxides. The protocol provided by Oxford Biomedical Research was 
closely followed to quantitatively determine lipid peroxidation products produced 
in cerebellar neuron cultures due to various treatments specified in the results 
section. The BCA protein assay was utilized to determine protein content under 
each treatment condition. A Beckman-Coulter Multimode DTX 880 multi-plate 
reader generated absorbance measurements at 595nm relative to MDA 
equivalents. Results of the lipid peroxidation assay were adjusted for protein 
content and compared to the MDA calibration curve to determine lipid 
peroxidation end product content.
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4.10 TNFa ELISA
The chicken TNFa ELISA measures secreted and cellular TNFa from 
neurons and glia. By following the kit’s published directions (Cusabio), we were 
able to detect a colorimetric change in the samples corresponding to TNFa 
abundance. A Beckman-Coulter Multimode DTX 880 multi-plate reader detected 
the color change at 450nm. The BCA protein assay was utilized to determine 
protein content under each treatment condition specified in chapter 5. Results of 
the TNFa ELISA were adjusted for protein content and compared to the TNFa 
calibration curve to determine TNFa content.
TNFa levels were determined for both secreted and cellular 
concentrations in cerebellar neurons and glia. Secreted TNFa was a measure of 
the TNFa present in the media as a result of treatments. After 48 hours of 
treatments (24-hr pre-/ 24-hr post-), the media was removed, sonicated and 
utilized in the TNFa ELISA (secretion). The same cultures were rinsed with PBS. 
Cells were removed through freeze/thaw cycling and scraping in ice cold PBS 
(the diluent used in the ELISA) and sonicated for 5 seconds. The BCA protein 
assay was used to determine protein content and appropriate delivery of samples 
for the ELISA (cellular TNFa).
4.11 Immunostaining and Fluorescent Labeling
Fluorescent labeling techniques were utilized to observe specific proteins 
present in the neurons and glia studied. Labeled cells were either viewed under
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a Nikon Eclipse TE 2000U inverted microscope or utilized in fluorescent density 
assays read by a Beckman Coulter Multimode DTX 880 multi-plate reader.
Cells used in microscopy were grown on coverslips coated with 10 ug/ml poly-D- 
lysine in borate buffer and then 1 mg/ml laminin in F-12. Cells were fixed for 20 
minutes with 4% paraformaldehyde, and permeabilized (cytoplasmic proteins) for 
20 minutes with 0.3% TritonX-100 in 1 X PBS prior to immunostaining. Cultures 
used for fluorescent density assays were not fixed. They were rinsed with HBSS, 
solubilized and scraped with TBST into eppendorf tubes to be immunolabeled.
Immunolabeling was initiated by blocking cells with 0.1% host serum for 
one hour, washing once with 1 X HBSS, and adding primary antibody in 0.1% 
Triton X-100. Cultures were refrigerated overnight at 4 degrees Celsius with 
agitation. Primary antibodies were then removed and cultures were rinsed twice 
with HBSS. Secondary antibodies tagged with fluorescent probes (FITC, TRITC, 
Alexa 555) were added to cultures for 2 hours at 4 degrees Celsius with 
agitation. Cultures were then rinsed three times with 1 X HBBS.
Cells were sometimes doubly labeled (LR/Nav1.6, LR/Nav-pan, NF/Cal) or 
counter stained with Hoechst (GFAP/Hoechst, NF/Cal/Hoechst). Double labels 
were produced by blocking cultures in 1% BSA in PBST for one hour, rinsing 
three times with 1 X HBSS, and incubating cells in a mixture of two primary 
antibodies in the refrigerator overnight. Cultures were rinsed three more times 
and incubated with a mixture of two secondary antibodies that were raised in 
different species and conjugated to different fluorochromes in 1% BSA for one
hour in the dark. Cultures were washed with 1 X HBSS five times in the dark. 
When counterstaining with Hoechst was needed, cells were incubated in 
0.5ug/ml Hoechst for one minute and rinsed with HBSS one time.
Cells that were destined for fluorescent microscopy were mounted to 
microscope slides with fluorescent mounting media. The coverslip was sealed 
with clear fingernail polish around the edges of to prevent drying. Slides were 
stored in the dark at room temperature. Cells used in fluorescent density assays 
were assayed for protein content and then pipetted into 96-well black falcon 
plates.
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4.12 Fluorescent Microscopy
Fluorescent microscopy was used to visualize lipid rafts, neuronal 
neurofilaments (NF), glial fibrillary acidic protein (GFAP), cellular DNA through 
Hoechst staining, cerebellar Purkinje neurons through Calbindin-D-28K labeling, 
and voltage-gated sodium ion channels through Nav1.6 and Nav-pan labeling. 
This technique was used to verify the cellular composition within cultures as well 
as to determine molecular localization within the cells. Additional fluorescent and 
ELISA assays were run to quantify what was visualized under a Nikon Eclipse TE 
2000U inverted microscope.
Neurons were labeled with Alexa Fluor 555-lipid raft labeling kit 
(Invitrogen) as per manufacturer’s directions which cross-linked fluorescent dye 
conjugates to plasma membrane ganglioside (GM1) specifically found in lipid 
rafts. Lipid raft labeling was often done in conjunction with Navi .6 and Nav-pan 
labeling to compare the effects of inflammation and blueberry supplementation 
on lipid raft/Nav channel localization and density.
4.13.1 Lipid Raft - Microscopy
Neurons were cultured for one week on poly-lysine and laminin coated 
glass coverslips and then incubated overnight in serum-free media prior to 
experimentation. Treatments were carried out in serum-free media. After the 
treatment period concluded, lipid rafts were labeled and cells fixed with 
paraformaldehyde, mounted with fluorescent media, and viewed under a Nikon 
Eclipse TE 2000U inverted microscope.
4.13.2 Lipid Raft -  Density Assay
Neurons and glia were cultured for one week in 6-well falcon plates coated 
with poly-D-lysine and laminin and then serum deprived overnight prior to 
experimentation. Treatments were delivered in serum free (SF) media. After 
treatment duration, neurons were labeled with Alexa Fluor 555-lipid raft labeling 
kit. Neurons were rinsed twice with cold HBSS, scraped and solubilized with
4.13 Lipid Raft Labeling
TBST, transferred into eppendorf tubes, sonicated for 5 seconds, and transferred 
into 96-well black falcon plates. Lipid raft density was measured as fluorescent 
density of Alexa Fluor 555 using the Beckman Coulter Multimode DTX 880 multi­
plate reader. Protein content was determined for each sample using the BCA 
protein assay kit (Pierce) and used to calculate fluorescent intensity per 
microgram of protein assayed.
4.14 Cell Fractionation
Cell fractionation was performed to separate cytosolic and plasma 
membrane fractions from cerebellar neurons. Neurons were sonicated in a 
sucrose buffer (20mM Tris-HCI, 2mM EDTA, 0.5mM EGTA, 2 mM AEBSF, 25 
ug/ml leupeptin, 0.33M sucrose, pH 8.0), and then centrifuged at 14000 rpm for 
20 minutes (Labnet Spectrafuge 16M). The cytosolic fraction (supernatant) was 
removed. The remaining membrane fraction (pellet) was re-suspended in a 
sucrose buffer without leupeptin. The membrane fraction was centrifuged for an 
additional 20 minutes. The plasma membrane (supernatant) was collected. A 
BCA protein assay was run on cytosolic and plasma membrane fractions to 
determine protein content per sample.
4.15 Nav Channel Localization
Cerebellar neuron cultures were treated with 24 hours of pretreatments 
(TNFa, E35, BBX and UA) and 24 hours of post-treatments. After completion of
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the 48 hour treatment phase, neurons were separated into cytosolic and 
membrane fractions as detailed in section 4.14. Neurons were labeled with Nav- 
pan as indicated in section 4.11. A BCA protein assay was performed to 
determine micrograms of protein per test sample. Cytosolic and membrane 
samples were transferred into 96-well black falcon plates and analyzed with the 
Beckman Coulter Multimode DTX 880 multi-plate reader to measure Nav density. 
Density of cytosolic and membrane Nav channels was reported as a percentage 
of the whole cell Nav density, thus illustrating differences in localization due to 
treatments.
4.16 Statistical Analysis
The data is presented as mean values ± standard deviations. Significant 
differences between treatments and within multiple groups (p<0.05 or p<0.001) 
were examined using analysis of variance (ANOVA) followed by Tukey’s Post 
hoc analyses. Statistical analyses were conducted utilizing StatsPro 2009 
professional software package. Significance is indicated in the results (Chapter 
5), and further statistical data (including n-values) is available in Appendix B.
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Chapter 5: Results
5.1 Isolation of Embryonic Chick Brain
Embryonic chick brains were cleanly dissected from ED10 chicks and 
inspected for deformity. Only anatomical normal brains were utilized in this 
research. Nearly 800 brains were dissected. A typical brain was photographed 
and labeled in Fig 5.1.
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Fig 5.1 Embryonic Chick Brain Photo (ED10)
The brain was further dissected into the forebrain, olfactory bulbs (anterior to the 
forebrain), and cerebellum. Nervous tissue was triturated to dissociate the 
neurons utilized in this study. All neurons were obtained from embryonic day ten 
(ED10) chicks. Spinal and DRG neurons were concurrently obtained from 
dissections of the spine (not pictured).
5.2 Cell Viability -  Microscopy of Neurons and Glia
The embryonic chick model was successfully utilized to culture dissociated 
neurons from the forebrain, cerebellum, spine, olfactory bulb and dorsal root 
ganglia, as well as glia from the cerebellum. Photographs of neuron (ED10) and 
glia (ED15) one-week old cultures are shown in Fig 5.2. These cultures provided 
the basis for all further experimentation. Visual inspection through a light 
microscope ensured only cultures free of microbial contamination and displaying 
good neurite outgrowth were used in this research. Neurons were recognized by 
their small cell body and long simply branched neurites; whereas, glia cells 
displayed larger cell bodies, more intricate processes, and often active cell 
division.
62
63
a. Cerebellum b. Forebrain c. Forebrain Neuron
d. DRG e. Spine f. Olfactory Bulb
g. Glia h. Glial Cell
Fig 5.2 Microscopy of Cell Cultures
Images of cell cultures taken under the light microscope reveal healthy cultures 
of each cell type studied in this research. Neuronal cultures (a.-f.) were obtained 
from ED10 chicks and glia cultures (g.&h.) were derived from ED15 chicks. 
Photographs were taken at one week in culture.
5.3 Immunochemical Confirmation of Neurons and Glia
To ensure our cultures were predominately composed of the neurons and 
glia of interest, immunochemical techniques were utilized. All neuron cultures 
were found to be densely packed with positive neurofilament (NF) fluorescence 
(Fig 5.3a). Neurofilaments are a neuron specific component of their 
cytoskeletons. Neuronal cultures contained only minimal numbers of astrocytes 
(Fig 5.3c), whereas glia cultures contained about 90% astrocytes and were void 
of neurons.
Astrocytes were positively identified through glial fibrillary acidic protein 
(GFAP) labeling, (Fig 5.3c). GFAP is an intermediate filament contributing to the 
shape and structure of astrocytes within the CNS. Any astrocytes present in 
neuronal cultures were part of the initial dissected tissue but did not multiply due 
to a mitosis inhibitor in the media. The glia cultures were designed to grow and 
multiply astrocytes (no mitosis inhibitor), but to preferentially kill neurons through 
alterations in plating substrate. Glia cultures were supplemented with a mitosis 
inhibitor 24 hours prior to experimental manipulation to hold the cell count 
constant.
The contribution of the Purkinje neuron was of particular interest in the 
unique molecular anatomy of the cerebellum. Cerebellar neuron cultures were 
labeled with a Purkinje specific marker, Calbindin-D-28K (Cal). Our cerebellar 
cultures contained an abundance of developing Purkinje neurons (Fig 5.3b) 
whose architecture was enhanced through astrocyte conditioned media.
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Embryonic chicks provided an ideal model to study Purkinje neurons. Unlike 
mammalian models, early embryonic avian cultures are nearly free from other 
cerebellar neurons (Baptista et al. 1994, Feirabend 1990, Feirabend et al. 1985).
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a. NF-Neuron b. Cal-Purkinje c. GFAP-Astrocyte
Fig 5.3. Immunochemical Identification of Neurons and Glia
Cultures were labeled with primary antibodies and secondary antibodies tagged 
with FITC or TRITC. Fluorescent microscopy confirms the presence of 
neurofilaments (marked with mouse NF-M/FITC) in neuronal cultures (a.), 
Purkinje neurons (marked by mouse Calbindin-D-28K/TRITC) in the cerebellar 
neuron cultures (b.), and astrocytes (marked by mouse GFAP/TRITC) in the glia 
cultures (c.).
5.4 Metabolic Cell Viability
Metabolic viability of neurons and glia was assessed utilizing an MTT 
assay In metabolically active cells, formazen dye was cleaved from tetrazolium 
salts and measured in the MTT colorimetric assay. Here we show that over a 24- 
hour periodi pre- and post-treatments of crude blueberry extracts (BBX),
nonpolar BBX fractions (NP), and ursolic acid (UA), increase the metabolic rate 
of cells even when exposed to TNFa (Fig 5.4). We also see in Fig 5.5, that 
alcohol did not metabolically kill the cells until significant concentrations above 
100 uM ethanol were delivered.
3 .5   --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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24-pre -treatment and 24-post treatment
Fig 5.4 Comparative Neuronal Viability
Dissociated neurons from multiple regions (C-Forebrain Cortex, Cb-Cerebellum, 
DRG, S-Spine, OB-Olfactory Bulb) were assessed for metabolic activity via ar, 
MTT assay. Pretreatments were applied for 24 hours, rinsed, and followed by 24 
hours of post treatment before the MTT assay was performed. Columns with no 
pretreatment reflect samples held in fresh SF media for 24 hours followed by the 
indicated treatments (NT, 10mM H2O2, 200ng/ml TNFa, 5ug/ml BBX, 5ug/ml NP, 
5ug/ml UA) for 24 hours. All results are reported as absorbance (595nm -  
620nm) normalized to the negative control (NT-no treatment) per microgram of 
protein assayed. Values are reported as P< 0.05 where ** indicates reduced 
viability from NT, ( * ) indicates increased viability from NT with the exception of 
DRG(BBX) and OB(NP), and “a” indicates improved viability from “A”.
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Fig 5.5 Comparative Viability of CNS, PNS, Glial Cells
The CNS is represented by cerebellar neurons (red), the PNS is represented by 
DRG neurons (green), and the glia cells (blue) were obtained from the 
cerebellum. Pretreatments were applied for 24 hours, rinsed and followed by 24 
hours of post treatment before the MTT assay was performed. Columns with no 
pretreatment reflect samples held in fresh SF media for 24 hours followed by the 
indicated treatments (NT, 1M H2O2 , 1mM H2O2 , 200ng/ml TNFa, 17.4 mM 
ethanol -  E17, E35. E100, E200, 5ug/ml NP) for 24 hours. All results are 
reported as absorbance (595nm -  620nm) normalized to the negative control 
(NT-no treatment) per microgram of protein assayed. Values are reported as P< 
0.05 where (**  ) indicates reduced viability from NT, and “a" and “b” indicate 
improved viability from “A” and “B” respectfully.
Cellular viability as a result of treatments was determined by the MTT 
assay (Fig 5.4 and Fig 5.5) and confirmed via light phase microscopy (not 
shown). Berry fractions were found to increase viability, whereas high doses 
(greater than 100mM) of ethanol and 200ng/ml TNFa began to kill cells within 24 
hrs. Visual inspection of cultures was often contrary to the results of the MTT 
assay. Although neurons remained viable in ethanol treated cultures less than 
100mM, their neurite outgrowth was stunted and blebbing of cellular membranes 
was observed. Presumably, cells can effectively metabolize compounds while 
undergoing structural demise. It was evident that cerebellar neurons were more 
sensitive to ethanol than the other neuronal types studied and glia cells were 
most resistant to ethanol toxicity. As a result of these findings, we turned to 
immunolabeling techniques that quantify some of these visually observable 
changes in cerebellar health.
5.5 Cerebellar Neuron and Glial Health
Neurons were labeled with NF, Cal, and Hoechst to assess changes in the 
cytoskeletal structure, Purkinje density, and DNA of cerebellar neurons. Glia 
were comparatively labeled with GFAP and Hoechst to quantify changes in 
astrocyte density and glial DNA. Fluorescent assays were performed to quantify 
changes in cellular health as measured by structure, specific cell density, and 
DNA nuclear stability in ethanol/TNFa treated cells. We also conducted assays 
to investigate the effectiveness of BBX/UA treatments and to identify proponents
of cellular demise due to increasing levels of ethanol. In general, we observed a 
progressive decline in cellular morphology that preceded cell death, but that can 
be both prevented and reversed by BBX/UA treatments.
The results of these assays support our observations from under the light 
microscope. It is apparent that NF and GFAP, both structural filaments, are 
quickly bolstered by BBX and UA supplementation as compared to less variable 
DNA levels (Figs 5.6 and 5.8). Blueberry treatments, whether before or after 
insult, prevent the ill effects of ethanol and TNFa to neurite outgrowth, Purkinje 
density, astrocyte density, and DNA stability (Figs 5.6 and 5.8). In cerebellar 
neurons, we also discover increasing doses of ethanol to most quickly diminish 
NF density, followed by Purkinje density, and lastly Hoechst labeled DNA (Fig 
5.7). In the glia culture we observed a more delayed decline of Hoechst labeling 
as compared to the neuronal culture while GFAP fluorescence was quickly 
reduced at physiological levels belowlOOmM ethanol (Fig 5.9).
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Fig 5.6 Cerebellar Neuronal Health
Cerebellar neuron cultures were dyed with Hoechst and doubly immuno-labeled 
with NF and Cal. Colormetric assays of Hoechst dyed cellular DNA is compared 
to fluorescent density assays of NF (marked with mouse NF-M/FITC) and Cal 
(marked with mouse Cal/TRITC). Pretreatments were applied for 24 hours, 
rinsed and followed by 24 hours of post treatment before performing colormetric 
and fluorescent density assays. Columns with no pretreatment reflect samples 
held in fresh SF media for 24 hours followed by the indicated treatments (NT, 
1mM H202, 200ng/ml TNFa, E35, 5ug/ml BBX, 5ug/ml UA) for 24 hours. Results 
are normalized to the negative control (NT) and reported as optical density (OD) 
per microgram of protein assayed. Values are reported as P< 0.05 where ( ** ) 
indicates reduced viability from NT and ( * ) indicates increased viability from NT.
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Fig 5.7 Effects of Increasing Ethanol on Cerebellar Neurons
Cerebellar neuron cultures were dyed with Hoechst and doubly immuno-labeled 
with NF and Cal. Colormetric assays of Hoechst dyed cellular DNA is compared 
to fluorescent density assays of NF (marked with mouse NF-M/FITC) and Cal 
(marked with mouse Cal/TRITC). Cultures were held for 24 hours under 
increasing levels of ethanol (0, 17.4, 35, 50, 100, 200, and 400 mM ) in SF 
media. Results are normalized to the negative control (NT) and reported as 
optical density (OD) per microgram of protein assayed.
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Fig 5.8 Cerebellar Glia Health
Cerebellar glia cultures were dyed with Hoechst and immuno-labeled with GFAP. 
Colormetric assays of Hoechst dyed cellular DNA is compared to fluorescent 
density assay of GFAP (marked with mouse GFAP/TRITC). Pretreatments were 
applied for 24 hours, rinsed, and followed by 24 hours of post treatment before 
performing colormetric and fluorescent density assays. Columns with no 
pretreatment reflect samples held in fresh SF media for 24 hours followed by the 
indicated treatments (NT, 1mM H2O2, 200ng/ml TNFa, E35, 5ug/ml BBX, 5ug/ml 
UA) for 24 hours. Results are normalized to the negative control (NT) and 
reported as optical density (OD) per microgram of protein assayed. Values are 
reported as P< 0.05 where ** indicates reduced viability from NT and * indicates 
increased viability from NT.
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Fig 5.9 Effects of Increasing Ethanol on Cerebellar Glia
Cerebellar glia cultures were dyed with Hoechst and immuno-labeled with GFAP. 
Colormetric assays of Hoechst dyed cellular DNA is compared to the fluorescent 
density assay of GFAP (marked with mouse GFAP/TRITC). Cultures were held 
for 24 hours under increasing levels of ethanol ( 0. 17.4, 35, 50, 100, 200, and 
400 mM ) in SF media. Results are normalized to the negative control (NT) and 
reported as optical density (OD) per microgram of protein assayed
5.6 ROS Detection
Cellular ROS production is a measure of oxidative stress that can be 
quantified by indirectly detecting levels of peroxide. The results of the ROS 
detection assay foretell the oxidative environment that may lead to oxidative 
damage of lipids, proteins, and DNA. In total, we found ethanol and TNFa 
treatments to increase neuronal ROS production, and conversely for blueberry 
extracts to decrease ROS. When applied before or after ethanol /TNFa, 
blueberry extracts successfully blunted ROS production. The cerebellar neurons
produced the most ROS at rest (Fig 5.10) and were most responsive to stimuli 
(TNFa and ethanol) as compared to forebrain cortical neurons, spinal neurons, 
and DRGs (Fig 5.11). This was true in both immediate response tests (45-90 
minutes), as well as after 24 hours of ethanol or TNFa treatments (Fig 5.11 and 
5.12). Additional ROS assays from chick forebrain cortical, spinal, DRG and 
human neuroblastoma cells are included in the Appendix with similar reductions 
in ROS production attributed to blueberry supplementation (Fig A.1 -  Fig A.5).
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Fig 5.10 Comparison of Total ROS Produced
ROS is detected as a measure of DCF fluorescent output at 535 nm per 
microgram of protein sampled. Neuronal cultures (C, Cb, DRG, and S) were held 
for 45 minutes under three conditions (no treatment, 1mM H202, and 200ng/ml 
TNFa). Values are reported as P< 0.001 where ( * ) indicates increased ROS 
generation compared to NT. Cerebellar neurons (Cb-xx) and forebrain cortical 
neurons (C-x) both produced significantly higher ROS than DRG and spinai (S) 
neurons, with Cb-xx > C-x.
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Fig 5.11 Cerebellar Neurons Generate Most ROS due to Ethanol
ROS is reported as a measure of relative fluorescence per microgram of protein 
sampled. All results are normalized to the negative control (NT). Neuronal 
cultures (C, Cb, DRG, and S) were held for 24 hours under six conditions (no 
treatment, 1mM H20 2, and 200ng/ml TNFa, 17.4 mM ethanol -  17E, 35E, and 
100E). Values are reported as P< 0.05 where ( * ) indicates increased ROS 
generation compared to NT. Cerebellar neurons (Cb-xx) produced higher ROS 
than other neuronal types.
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Fig 5.12 Immediate ROS Generation in Cerebellar Neurons
ROS is reported as a measure of fluorescent output at 535 nm per microgram of 
protein sampled taken at 45 minutes (after pretreatments) and at 90 minutes 
(after pre- and post-treatments are complete). Cerebellar neuronal cultures were 
held for 45 minutes under different conditions. Columns NT through UA had the 
same pre- and post-treatments and the remaining columns were pretreated with 
5ug/ml BBX, 5ug/mi NP, 5ug/ml UA, and 200ng/ml TNFa (last three columns). 
Pretreatments were rinsed and post-treatments were added for another 45 
minutes: no treatment (NT), 1mM H20 2, 200ng/ml TNFa, 5ug/ml BBX, 5ug/ml 
NP, 5ug/ml UA, 200ng/ml TNFa, 5ug/ml BBX, 5ug/ml NP, and 5ug/ml UA. 
Values are reported as P< 0.05 where “a” indicates decreased ROS generation 
compared to “A". BBX** is significantly lower than NT while ( * ) is higher. ROS 
was decreased (P< 0.001) at 90 minutes ( x ) by BBX, NP; and UA compared to 
45 minutes.
Interestingly, we discovered that the highest levels of ROS are generated 
at levels seen in both social and binge drinkers, (Fig 5.13). Extreme 
concentrations of alcohol likely alter cellular membrane dynamics and metabolic 
processes that are necessary to produce ROS. This same ethanol concentration 
curve was applied to explore the effects on viability (Fig 5.7), lipid peroxidation 
(Fig 5.21), TNFa production (Fig 5.24), lipid raft density (Fig 5.28), and Nav 
channel density (Fig 5.33).
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Fig 5.13 ROS Generated by Cerebellar Neurons and Glia with Increasing 
Ethanol Exposure - ROS is reported as a measure of relative fluorescence 
normalized to the control per micrograms of protein sampled. Cerebellar neuron 
and glia cultures were held in increasing concentrations of ethanol (0, 17.4, 35, 
50, 100, 200, 400 mM) in serum-free media for 24 hours.
The central nervous system (CNS) is thought to be severely affected by 
alcohol abuse. Obvious delirious effects are presented by loss of coordination, 
slurred speech, poor decision making, and loss of inhibitions. We sought to 
compare representative neurons from the CNS and the peripheral nervous 
system (PNS) to identify whether the CNS may produce more ROS due to 
ethanol. At physiological observed levels of blood alcohol content (BAC), the 
CNS does indeed produce more ROS than both the PNS and glia cells (Fig 
5.14). At these concentrations of ethanol (17.4mM ethanol = 0.08 BAC, and 
35mM ethanol = 0.16 BAC), the nonpolar (NP) fraction of blueberries blunted 
ethanol induced ROS generation as both a pre- and post-treatment (Fig 5.14). 
The ursolic acid used through this study was isolated from the nonpolar (NP) 
fraction.
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Fig 5.14 Comparative ROS Response: CNS vs. PNS vs. Glia
The CNS is represented by cerebellar neurons (red), the PNS is represented by 
DRG neurons (green), and the glia cells (blue) were obtained from the 
cerebellum ROS is reported as a measure of fluorescent output at 535 nm per 
microgram of protein sampled taken at 48 hours after pre- and post-treatments 
are complete. Results are normalized to the negative control (NT). Cultures 
were held for 24 hours under different conditions. Columns NT through NP had 
no treatment and the remaining columns were pretreated with 200ng/ml TNFa, 
5ug/ml NP, 17.4 mM ethanol, 35mM ethanol, and 100mM ethanol.
Pretreatments were rinsed and post-treatments were added for another 24 hours: 
NT (1), 1mM H20 2 (2), 200ng/ml TNFa (3), 17E (4), 35E (5), 100E (6), NP (7&8), 
TNFa (9), NP (10-12). Values are reported as P< 0.05 where “a, b, c & d” 
indicate decreased ROS generation compared to “A, B, C & D” respectfully. 
Treatments indicated by ( * ) increased ROS while (NP **) resulted in significantly 
lower ROS than NT.
5.7 Antioxidant Capacity
The antioxidant capacity of Alaska wild blueberries stands at up to ten 
times that of commercially cultivated berries as assessed by copper reduction 
potential converted to uM Trolox (antioxidant) equivalents. Crude blueberry 
extracts (BBX) were shown to have the highest antioxidant capacity (1195 uM 
Trolox equiv), whereas ursolic acid isolated from the berries was significantly 
lower (Fig 5.15). Interestingly, ursolic acid was as effective as both BBX and NP 
in reducing ROS (Fig 5.18), therefore avenues other than direct ROS scavenging 
potential may be relevant to ursolic acid’s capacity as an antioxidant.
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Fig 5.15 Antioxidant Capacity of Wild Alaska Blueberries
Total antioxidant power was determined by the ability of blueberry fractions to 
reduce copper. Antioxidant capacity is reported in calibrated Trolox equivalents 
as measured by colormetric analysis. The columns include: 1) blank (dilutent 
only), 2) crude blueberry extracts, 3) non-polar blueberry fraction, 4) polar 
blueberry fraction, 5) isolated ursolic acid. Results are calibrated to reflect 
approximate antioxidant capacity found in one cup of fresh blueberries. Values 
are reported as P< 0.05 where ( **) indicates reduced antioxidant capacity from 
P and NP: ( * )  indicates increased antioxidant capacity from P and NP.
The total antioxidant capacity of all neurons was similar with the exception 
of the olfactory bulb neurons which were significantly lower (Fig 5.16). 
Interestingly, loss of smell is commonly found as a preliminary sign of 
Parkinson’s disease, Alzheimer’s disease, some genetically linked cerebellar 
ataxias, and alcoholism (Haehner et al. 2007. Abele et al. 2003, Connelly et al. 
2003, Rupp et al. 2003, Nordin et al. 1995). Cerebellar glia cells displayed a
30% increase in antioxidant capacity compared to neurons (Fig 5.16). Alcohol 
exposure reduced this capacity in all cells. When berry fractions were applied to 
neurons and glia cells, the cellular antioxidant capacity increased and prevented 
depression of cellular antioxidant defenses by alcohol (Fig 5.18).
Fig 5.16 Innate Antioxidant Capacity of Neurons and Glia
Total antioxidant power was determined by the ability of different cell types to 
reduce copper. Antioxidant capacity is reported in calibrated Trolox equivalents 
as measured by colormetric analysis. The columns include neurons from the 
forbrain cortex (C), cerebellum (Cb), spine (S), olfactory bulb (OB), and DRGs. 
Glia cells (G) were obtained from the cerebellum. Values are reported as P<0.05 
where ( ** ) indicates reduced antioxidant capacity from other neurons while ( * ) 
indicates increased antioxidant capacity from other neurons.
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Fig 5.17 Relative Antioxidant Potential of Treatments
Total antioxidant power was determined by the ability of treatments to reduce 
copper and measured by colormetric analysis. Reduction potential is relative to 
the negative control blank (BLK). The columns include: 1) blank (dilutent only), 2) 
5ug/ml crude blueberry extracts, 3) 5ug/ml non-polar blueberry fraction, 4) 5ug/ml 
polar blueberry fraction, 5) 5ug/ml isolated ursolic acid, 6) 35mM ethano! Values 
are reported as P< 0.05 where ( * ) indicates increased antioxidant capacity from 
the BLK.
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Fig 5.18 Total Antioxidant Capacity of Cerebellar Neurons and Glia
Total antioxidant power was determined by the ability of cerebellar neurons (Cb) 
and glia (G) to reduce copper after undergoing 48 hours of treatments (24 hour 
pre- and 24 hour post-treatments). Antioxidant capacity is reported in calibrated 
Trolox equivalents as measured by colormetric analysis. Cultures were held for 
24 hours under different conditions. Columns NT through UA had no treatment 
and the remaining columns were pretreated with 200ng/ml TNFa (9&10), and 
35mM ethanol (11-13). Pretreatments were rinsed and post-treatments were 
added for another 24 hours: NT, 200ng/mi TNFa, E17, E35, E100, 5ug/m! BBX, 
5ug/ml NP, 5ug/ml UA, BBX, NP, UA, NP, UA. Values are reported as P< 0.05 
where ( ** ) indicates decreased antioxidant capacity from the control (NT). All 
other treatments resulted in increased antioxidant capacity.
The data presented from the lipid peroxidation assays clearly illustrate that 
exposure to ethanol and TNFa induced peroxidation of the lipids within cellular 
membranes. Lipid peroxidation is simply the degradation of lipids via oxidation. 
As evident from the ROS assays, ethanol and TNFa create an oxidative 
environment in the cultured neurons and glia. Lipid peroxidation is therefore an 
expected consequence of heightened ROS production. Since blueberry extracts 
successfully negated ethanol/TNFa induced ROS, we anticipated similar 
abatement in lipid peroxidation end products.
Blueberry fractions ably protected the cerebellar membranes from lipid 
peroxidation (Fig 5.19). Additionally, depletion of membrane cholesterol by 
methyl-beta-cylcodextrin (MBCD) reduced peroxidation end product (MDA), 
possibly indicating the role of lipid rafts in oxidative events within the neuron (Fig
5.20). Comparable to results presented in Fig 5.13, ROS production, lipid 
peroxidation assays revealed a peak in lipid peroxidation end products at 
physiologically observed BAC levels (Fig 5.21).
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5.8 Lipid Peroxidation
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Fig 5.19 Blueberry Fractions Blunt Lipid Peroxidation Induced by TNFa 
and 35mM Ethanol in Cerebellar Neurons - Lipid peroxidation products were 
measured through a colorimetric assay and calibrated to equivalents of MDA per 
microgram of protein per sample. Cerebellar neurons were cultured for 24 hours 
under pretreatment conditions, rinsed and followed with 24 hours of post­
treatments. Concentrations of blueberry fractions {BBX, NP; and UA) were all 
5ug/ml and TNFa was 200ng/mi, The first seven columns were held in untreated 
media as a pretreatment, followed by the indicated post-treatments. Values are 
reported as P< 0.05 where “a” and “b” indicate decreased lipid peroxidation 
compared to “A” and “B” respectfully. Treatments ( ** ) significantly lowered lipid 
peroxidation while ( * ) caused an increase as compared to NT.
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Fig 5.20 Depletion of Lipid Rafts Prevents Lipid Peroxidation of Ethanol 
Treated Cerebellar Neurons - Lipid Peroxidation end product (MDA) values are 
negated by the cholesterol depletion drug MBCD. Cerebellar neurons were 
cultured as follows: 1) 24 hours of serum free media (no treatment), 2) 23.5 
hours of NT followed by 30 minutes of 10mM methyl-beta-cyclodextrin (MBCD), 
3) 24 hours of 35mM ethanol, 4) 30 minutes of 10mM MBCD pre-treatment, 
followed by 23.5 hours of 35mM ethanol. Values are reported as P< 0.05 where 
( ** ) significantly lowered lipid peroxidation while ( * ) caused an increase as 
compared to NT.
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Fig 5.21 Lipid Peroxidation Peaks at Physiologically Relevant 
Concentrations of Ethanol in Cerebellar Neurons - Results are calibrated to 
reflect the production of lipid peroxidation end product (MDA) as measured by 
colorimetric analysis per microgram of protein. Cerebellar neuron cultures were 
treated with increasing levels of ethanol (0, 17.4, 35, 50, 100, 200, 400 mM) for 
24 hours prior to reading absorbance assays.
Inflammatory cytokines are secreted from cells all over the body to initiate 
the acute phase of inflammation. Our study sets out to determine the 
cerebellum’s response to ethanol by measuring both secreted TNFa and cellular 
TNFa levels in neurons and glia. Secreted TNFa was a measure of TNFa 
secreted into the media over a 24 hour period. Cellular TNFa was a measure of 
TNFa expression within the cells and bound to TNFa receptors.
Cerebellar glia cells clearly secreted more TNFa than neurons (Fig 5.22) 
and do so in an ethanol dose dependent manner (Fig 5.24). Assays performed 
on cellular TNFa levels did not demonstrate large disparity between glia and 
neurons (Fig 5.23). Importantly, blueberry fractions return TNFa levels to normal 
in both neurons and glia within 24 hours of BBX/UA treatments after ethanol 
exposure (Fig 5.22 and Fig 5.23). Disruption of lipid rafts through MBCD 
pretreatments likewise reduced TNFa production (Fig 5.25). Once again, a 
relationship between lipid rafts and inflammatory processes is indicated.
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5.9 TNFa Production
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Fig 5.22 Cerebellar Glia vs. Neuronal TNFa Secretion
The media housing cerebellar glia and neurons was analyzed to determine TNFa 
secretion from the cells into the media. Colormetric assays were used to 
evaluate changes in TNFa production due to culturing conditions. Cerebellar 
neurons were cultured for 24 hours under pretreatment conditions, rinsed and 
followed with 24 hours of post-treatments The first five columns were held in 
untreated media as a pretreatment, followed by the indicated post-treatments. 
Concentrations of blueberry fractions (BBX and UA) were 5ug/ml. Values are 
reported as P< 0.05 where “a" indicates decreased TNFa secretion compared to 
“A" Treatments (**  ) significantly lowered TNFa secretion while ( *  ) caused an 
increase as compared to NT. Cerebellar neurons “x” secrete significantly less 
TNFa than cerebellar glia, (P<0.001).
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Fig 5.23 Cerebellar Glia vs. Neuronal Cellular TNFa
Cerebellar glia and neurons were analyzed to determine cellular levels of TNFa. 
Colormetric assays were used to evaluate changes in TNFa within the cells due 
to culturing conditions. Cerebellar neurons were cultured for 24 hours under 
pretreatment conditions, rinsed and followed with 24 hours of post-treatments. 
The first five columns were held in untreated media as a pretreatment, followed 
by the indicated post-treatments. Concentrations of blueberry fractions (BBX and 
UA) were 5ug/ml. Variations in cellular TNFa are not statistically significant.
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Fig 5.24 Glial TNFa Increases with Increased Ethanol Exposure
Cerebellar alia were analyzed to determine cellular levels of TNFa due to 
increasing concentrations of ethanol exposure. Colormetric assays were used to 
evaluate changes in TNFa within the cells due to culturing conditions. Glia were 
cultured in ethanol concentrations of 0, 17.4, 35, 50, 100, 200, and 400 mM for 
24 hours.
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Fig 5.25 Disruption of Lipid Rafts Negates TNFa Secretion in Neurons
The cholesterol depletion drug methyl-beta-cyclodextrin (MBCD) was used to 
disrupt lipid rafts. Cerebellar neurons were cultured as follows: 1) 24 hours of 
serum free media (no treatment), 2) 23.5 hours of NT followed by 30 minutes of 
10mM MBCD, 3) 24 hours of 35mM ethanol, 4) 30 minutes of 10mM MBCD pre­
treatment, followed by 23.5 hours of 35mM ethanol. Values are reported as P< 
0.05 where “a” indicates decreased TNFa secretion compared to “A”. Treatments 
( * ) caused a significant increase as compared to NT while ( ** ) caused a 
decrease.
5.10 Lipid Rafts
5.10.1 Lipid Rafts -  Cerebellar Neurons
Lipid rafts were visualized in cerebellar and forebrain cortical neurons 
using Alexa 555 cholera toxin GPI linked fluorescent labeling. Fluorescent 
microscopy revealed the greatest intensity of lipid rafts localized to the soma with
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punctuated presence in the developing neurites (Fig 5.26 & Fig 5.29). Neurons 
and glia were positively identified using neurofilament and GFAP secondary 
staining (Fig 5.3a & c). Addition of TNFa and ethanol greatly increased the lipid 
raft signal into larger distinct masses. Pretreatment with blueberries or MBCD 
prevented the amplified lipid raft signal and post treatment with berries produced 
similar results. Lipid raft intensity was then quantified through fluorescent 
intensity readings (Fig 5.27 & Fig 5.30).
Fig 5.26 Fluorescent M icroscopy of Lipid Rafts in Cerebellar Neurons 
Lipid rafts were visualized under a Nikon Eclipse TE 2000U inverted microscope 
utilizing Alexa 555 cholera toxin GPI linked fluorescent labeling. Cerebellar 
neurons were cultured for 24 hours under pretreatment conditions, rinsed and 
followed with 24 hours of post-treatments. The photographs (a-c) were held in 
untreated media as a pretreatments and followed by the indicated post­
treatments (NT-no treatment, 200ng/mi TNFa, and E35 - 35mM ethanol). Image 
(d) was pretreated with E35 followed by 5ug/ml BBX and image (e) was 
pretreated with 200ng/ml TNFa followed by 5ug/ml BBX.
a. NT b TNFa c. E35 d. E35 + BBX e. TNFa + BBX
Lipid rafts were visualized in cerebellar neurons using Alexa 555 cholera 
toxin GPI linked fluorescent labeling (Fig 5.26). Fluorescent microscopy reveals 
the greatest intensity of lipid rafts localized to the soma with punctuated presence 
in the developing neurites. Neurons and glia were positively identified using 
neurofilament and GFAP secondary staining (not shown). Addition of TNFa and 
ethanol greatly increased the lipid raft signal into larger distinct masses (Fig 
5.26b and c) and is quantified in Fig 5.27. Pretreatments and post-treatments 
with BBX and UA prevent the amplified lipid raft signal (Fig 5.27).
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Fig 5.27 Density of Lipid Rafts in Cerebellar Neurons
Lipid rafts were quantified through fluorescent density assays with Alexa 555 
cholera toxin GPI linked fluorescent labeled cultures. Cerebellar neurons were 
cultured for 24 hours under pretreatment conditions, rinsed and followed with 24 
hours of post-treatments. A 30-minute treatment of methyl-beta-cyclodextrin 
(MBCD) was used as a negative control. All columns indicating a single 
treatment were held in untreated media prior to post-treatments. The following 
concentrations were used in treated medias: 200ng/ml TNFa, 35mM ethanol, 
5ug/ml BBX, 5ug/ml UA. Fluorescent density is quantified per microgram of 
protein and normalized to the untreated control (NT). Values are reported as P< 
0.05 where “a” and “b” indicate decreased lipid raft densities compared to “A” and 
“B" respectfully, Treatments ( * ) caused a significant increase as compared to 
NT while ( ** ) caused a decrease.
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Fig 5.28 Effects of Increasing Ethanol on Lipid Raft Density
Lipid rafts were labeled with Alexa 555 cholera toxin GPI linked fluorescence. 
Cerebellar glia (blue) and neurons (red) were cultured for 24 hours under 
increasing concentrations of ethanol (0, 17.4, 35, 50, 100, 200, 400mM). 
Fluorescent density is quantified per microgram of protein and normalized to 0 
mM ethanol. Values are reported as P< 0.05 where treatments ( * ) caused a 
significant increase in lipid raft density as compared to E0 while ( ** ) caused a 
decrease.
5.10.2 Lipid Rafts -  Forebrain Cortical Neurons
Lipid rafts were visualized in forebrain cortical neurons using Alexa 555 
cholera toxin GPI linked fluorescent labeling as described in section 5.10.1. 
Addition of TNFa greatly increased the lipid rafts into larger distinct masses (Fig 
5.29). Pretreatment with UA or MBCD prevented the amplified lipid raft signal
E0 E17 E35 E50 E100 E200 E400
24-hr Ethanol treatments (mM)
and post- treatment with UA produced similar results. Lipid raft intensity was 
then quantified through fluorescent intensity readings (Fig 5.10.2.2).
a. NT b. MBCD c. UA d. TNFc e. UA+TNFa f. TNFa+UA
Fig 5.29 Fluorescent Microscopy of Lipid Rafts in Forebrain Cortical 
Neurons Neurons were labeled with Alexa fluor 555-lipid raft labeling kit, fixed, 
mounted and viewed under a Nikon Eclipse TE 2000U inverted microscope. 
Cultures were photographed after the following conditions: a) 48-hrs no 
treatment (NT), b) 30-minutes, 10 mM methyl-B-cyclodextrin (MBCD), followed 
by 48-hrs NT, c) 24-hrs NT followed by 24-hrs UA (5 ug/ml), d) 24-hrs NT 
followed by 24-hrs TNFa (200 ng/ml), e) 24-hrs UA (5 ug/ml), followed by 24-hrs 
TNFa (200 ng/ml), f) 24-hrs TNFa (200 ng/ml) followed by 24-hrs UA (5ug/ml). 
Cholesterol depletion via MBCD reduced lipid raft formation comparable to that of 
UA whereas TNFa increased lipid raft formation. Pretreatment and post­
treatment with UA blunted the TNFa induced lipid raft increase.
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Fig 5.30 Density of Lipid Rafts in Forebrain Cortical Neurons
Lipid rafts were quantified with optical density assays. Forebrain cortical neurons 
were cultured for 24 hours under pretreatment conditions, rinsed and followed 
with 24 hours of post-treatments. A 30-minute treatment of methyl-beta- 
cydodextrin (MBCD) was used to deplete cholesterol and disrupt lipid rafts. All 
columns indicating single treatments were held in untreated media prior to post­
treatments. The following concentrations were used in treated medias: 10mM 
MBCD, 1mM H202, 200ng/ml TNFa, 35mM ethanol, 5ug/ml BBX, and 5ug/ml 
UA. Neurons were labeled with Alexa 555 cholera toxin GPI linked fluorescence 
after treatments. Fluorescent density was quantified per microgram of protein 
and normalized to the untreated control (NT). Values are reported as P< 0.05 
where “a” and “b” indicate decreased lipid raft densities compared to ‘A" and “B”. 
Treatments ( * ) caused a significant increase as compared to NT while ( ** ) 
caused a decrease.
5.10.3 Colocalization of Lipid Rafts and Nav Channels
Encouraging data suggests the dependence of Nav channels on lipid raft 
platforms. Immunofluorescent microscopy indicates collocalization of lipid rafts 
and voltage gated sodium ion channels in the soma and neurites (Fig 5.32) of 
Nav-pan labeled cells. Nav-pan is a general marker that tests positive for all 
isoforms of Nav channels whereas Navi .6 (Fig 5.31 b) is specific only for the 
Navi .6 isoform. We discovered that Navi .6 channels are not present in the 
developing axons and dendrites at this stage of maturity but were present in the 
soma (Fig 5.31). According to literature, Navi .6 will replace Navi .2 channels in 
the neurites after oligodendrite (CNS) or Schwann cell (PNS) dependent 
meylenation occurs (Afshari et al. 2004, Schaller and Caldwell 2000, Schaller 
and Caldwell 2003, Raman et al. 1997). Navi .6 channels are integral to 
resurgent current and the firing patterns of neurons. Because Navi .6 expression 
is limited to the soma in our samples, we chose to use Nav-pan measurements 
for the rest of this study. Our initial findings indicate that alterations in the lipid 
rafts will most likely affect sodium ion channel placement in the membrane and 
thus function. This has great implications for the neuron as sodium ion channels 
are responsible for action potential. Immediate and lasting changes to neuronal 
membranes due to alcohol toxicity is medically relevant to alcoholics.
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Fig 5.31 Lipid Rafts and Nav1.6 Channels in DRG Neurons
DRG cultures were doubly labeled with Alexa Fluor 555 (Lipid Raft) and mouse 
SCN8A (Navi .6) antibody. Fluorescent microscopy indicates the presence of 
Navi .6 channels (with secondary labeling of FITC) only in the soma (b.), 
whereas lipid rafts are also present in neurites (a.).
a. Lipid Raft b. Nav-pan
Fig 5.32 Lipid Rafts and Nav-pan Channels in DRG Neurons
DRG cultures were doubly labeled with Alexa Fluor 555 (Lipid Raft) and rabbit 
Nav-pan antibody/FITC. Nav-pan positively identifies all sodium ion channel 
isoforms. Fluorescent microscopy indicates the colocalization of lipid rafts with 
Nav-pan in both soma and neurites.
Increasing concentrations of alcohol once again reveal a similar pattern of 
response between lipid rafts and Nav channels. The increase in lipid rafts at 
physiological levels is consistant with ROS (Fig 5.13) and lipid peroxidation (Fig
5.21) assays. It is clear that Nav channel densities also dramatically intensify at 
this range (35-50mM ethanol).
Sodium ion channel expression was also found to positively correlate to 
lipid raft density in response to treatments specified in Fig 5.34. Both densities 
were heightened due to the inflammatory effects of ethanol and TNFa, reduced 
due to BBX and UA, and normalized due to intervening blueberry treatments. 
When lipid rafts were intentionally disrupted by the cholesterol depleting agent, 
MBCD, membrane Nav channel expression was also abated.
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Fig 5.33 Lipid Raft and Nav Channel Density in Cerebellar Neurons with 
Increasing Ethanol Concentration - Cerebellar neurons were cultured in 
increasing concentrations of ethanol (0, 17.4, 35, 50, 100, 200, 400 mM) for 24 
hours. Neurons were doubly labeled with Alexa Fluor 555 (Lipid Raft) and rabbit 
Nav-pan antibody/FITC. Fluorescent density (optical density -  OD), is quantified 
per microgram of protein and normalized to 0 mM ethanol. Lipid rafts (blue) and 
Nav channel (red) densities reveal similar plot patterns and both display peak 
intensities at 35 mM ethanol (twice the legal blood alcohol content for driving). 
The ROS generation plot (green dots) was transferred from Fig 5.13.
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Fig 5.34 Lipid Rafts and Nav Channels Display Common Expression in 
Cerebellar Neuron Membrane Fractions - Cerebellar neurons were cultured 
for 24 hours under pretreatment conditions, rinsed and followed with 24 hours of 
post-treatments. The first seven columns were held in untreated media as a 
pretreatment, followed by the indicated post-treatments. Methyl-beta- 
cyclodextrin (MBCD) was utilized to disrupt lipid rafts through cholesterol 
depletion in a 30 minute treatment. At the completion of treatments, neurons 
were doubly labeled with Alexa Fluor 555 (Lipid Raft) and rabbit Nav-pan 
antibody/FITC. Fluorescent density (optical density -  OD), is quantified per 
microgram of protein and normalized to cultures given no treatments (NT). 
Values are reported as P< 0.05 where “a” and “b” indicate decreased expression 
compared to “A” and “B” respectfully. Treatments ( * ) caused a significant 
increase as compared to NT while ( * * )  caused a decrease.
5.11 Cellular Fractionation and Nav Channel Localization
In preparation for specific localization of Nav channels, we first needed to 
confirm our cell fractionation techniques. Cerebellar neurons were treated as 
indicated by Fig 5.35. Cells were fractionated and then assayed to determine 
lipid raft densities. As expected, the lipid raft densities of whole cell and 
membrane fractions (Fig 5.35) closely resembled the experimental results 
presented in Fig 5.34. The cytosolic fraction (Fig 5.35) was essentially void of 
lipid rafts and confirms the fractionation procedures were effective. The next 
phase of the study was to repeat this particular experiment for Nav channels.
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Fig 5.35 Lipid Raft Density in Cerebellar Fractions
Cerebellar neurons were split into membrane/cytosol fractions and tested for lipid 
raft fluorescence to ensure proper cellular fractionation Successful fractionation 
techniques should not reveal GMI tagged lipid rafts in the cytosol. Pre- and post­
treatment protocols match those identified in Fig 5.34. Relative fluorescence was 
compared to whole cell untreated cells (NT). Values are reported as P< 0.05 
where “a” and “b” indicate decreased densities compared to “A" and “B" 
respectfully. Treatments ( * ) caused a significant increase as compared to NT 
while ( ** ) caused a decrease.
Cells were treated as indicated in Fig 5.36 and then separated into cytosol 
and membrane fractions. We then determined the localization of sodium ion 
channels in response to ethanol, TNFa, and blueberry fractions. Preliminary 
results indicate that sodium ion channels are localized within lipid rafts (Fig 5.32) 
and follow the same variations in density due to prescribed treatments (Fig 5.34) 
as lipid rafts. Additionally we observe that Nav channels may move into the 
cytosol when lipid rafts are disrupted by blueberry fractions or MBCD (Fig 5.36). 
Independent whole-cell labeling of Nav-pan (Fig 5.37) confirmed the combined 
expression of Nav channels in the membrane and cytosolic fractions. Nav 
channels are known to tightly associate with cytoskeleton proteins such as 
ankyrin, and may be quickly relocated into the cytosol (Caldwell et al. 2000).
More research needs to be conducted to elucidate the mechanism underlying 
this pathway and the relevance of sodium ion channels in neuroinflammation and 
alcohol abuse.
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Fig 5.36 Localization of Nav Channels in Cerebellar Neurons
Cerebellar neurons were cultured for 24 hours under pretreatment conditions, 
rinsed and followed with 24 hours of post-treatments. The first seven columns 
were held in untreated media (NT) as a pretreatment, followed by the indicated 
post-treatments. Methyl-beta-cyciodextrin (MBCD) was utilized to disrupt lipid 
rafts through cholesterol depletion in a 30 minute treatment. Reagent 
concentrations were as follows: lOmM MBCD, 200ng/ml TNFa, 35mM ethanol, 
and 5ug/ml of BBX and UA. At the completion of treatments, neurons were 
fractioned into membrane and cytosol samples and labeled with rabbit Nav-pan 
antibody/FITC. Fluorescent density is reported per microgram of protein. This 
style of graph did not support use of error bars to indicate the standard deviation 
of the 7 samples analyzed. Values are reported as P< 0.05 where “a" and “b” 
indicate decreased densities compared to “A” and “B” respectfully. Treatments 
( * ) caused a significant increase as compared to NT while ( ** ) caused a 
decrease.
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FigS .37 Nav Channel Expression in Whole-cell Cerebellar Neurons
Cerebellar neurons were cultured for 24 hours under pretreatment conditions, 
rinsed and followed with 24 hours of post-treatments. The first seven columns 
were held in untreated media (NT) as a pretreatment, followed by the indicated 
post-treatments. Methyl-beta-cyclodextrin (MBCD) was utilized to disrupt lipid 
rafts through cholesterol depletion in a 30 minute treatment. Reagent 
concentrations were as follows: 10mM MBCD, 200ng/ml TNFa, 35mM ethanol, 
and 5ug/ml of BBX and UA. At the completion of treatments, neurons were 
solubilized and labeled with rabbit Nav-pan antibody/FITC to indicate total 
expression of Nav channels in membranes and cytosol. Fluorescent density is 
normalized to the control and reported per microgram of protein. Values are 
reported as P< 0.05 where “a” and “b” indicate decreased expression compared 
to “A" and “B” respectfully. Treatments ( * ) caused a significant increase as 
compared to NT while ( ** ) caused a decrease.
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Chapter 6: Discussion
6.1 Overview
High rates of alcohol abuse coupled with inadequate nutrition may 
increase chronic inflammation and predispose individuals to future 
neurodegenerative disease. Oxidative stress is a common thread among the 
complex diseases associated with alcohol abuse and therefore interventions that 
disrupt the inflammatory cascade leading to oxidative stress are critical. 
Blueberries represent an inexpensive and accessible means to mitigate this 
process. Blueberries and ursolic acid have shown great promise in abutting 
alcohol induced oxidative stress in the liver and cardiovascular system, but very 
little is known about their ability to confer protection to the brain and nervous 
system in cases of alcohol abuse (Saravanan et al. 2006, Saravanan and 
Pugalendi 2006, Saraswat et al. 2000).
This study aimed to determine whether blueberry extracts could effectively 
combat oxidative stress and neuroinflammation invoked by alcohol abuse. 
Utilizing the embryonic chick model, neurons and supporting glia cells were 
dissociated from different regions of the brain and peripheral nervous system. 
These cells were grown in culture and stimulated with increasing levels of 
ethanol over time to produce physiologically relevant models. Blueberry extracts 
(BBX) and the isolated compound, ursolic acid (UA), were applied before 
(prevention) or after (intervention) alcohol exposure. Convincingly, both
/
preventive and therapeutic blueberry treatments yielded similar beneficial 
outcomes.
6.2 BBX and UA Blunt Ethanol Induced Oxidative Stress
The results of this study clearly indicate that Wild Alaska Bog Blueberries 
exhibit potent anti-inflammatory properties that protect neurons and glia from the 
toxic inflammatory effects of alcohol. At physiologically relevant doses of alcohol, 
equivalent to blood alcohol content of 0.08 (17.4 mM) and above, oxidative stress 
was greatly amplified at the cellular level (Fig 5.11). Supplementation with 
blueberry extracts and ursolic acid was found to improve cellular viability (Figs 
5.4, 5.6, and 5.8), prevent alcohol toxicity (Figs 5.5, 5.6, and 5.8), and reverse 
alcohol induced neuroinflammation by drastically reducing oxidative stress. 
Blueberry biomolecules up-regulated cellular antioxidant defenses (Fig 5.18), 
reduced oxygen radicals (Figs 5.12, 5.14, A.1-A.4), prevented cellular membrane 
degradation (Fig 5.19), disrupted inflammatory signaling via lipid rafts (Figs 5.22, 
5.25, and 5.27), and improved cellular architecture and morphology (Figs 5.6 and 
5.8). While crude blueberry extracts are known to contain antioxidants that 
impart protection from oxidative stress, ursolic acid is not.
6.3 Ursolic Acid Modulates Lipid Rafts
Ursolic acid does not demonstrate a strong reducing power of free radicals 
(Fig 5.15); however, it was clearly effective in reducing overall ROS production in
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both neurons and glia (Fig 5.18). Therefore, ursolic acid must exert its 
antioxidant power through an indirect means. Labeling of lipid rafts clearly 
indicates ursolic acid’s ability to block the coalescence and increased density of 
lipid rafts within cellular membranes (Figs 5.29, Fig 5.30, and Fig 5.27).
Ursolic acid may interrupt subunit assembly of pro-inflammatory enzymes 
that are dependent on lipid raft platforms to become functional. Two such 
membrane bound enzymes, NOX and nSMase, generate a cycle of up-regulated 
ROS production when neurons are subject to inflammatory cytokine TNFa. If 
functional assembly/activation of these enzymes is prohibited, ROS production 
should be tempered even when subject to TNFa or the inflammatory effects of 
ethanol. We propose that ursolic acid negates the inflammatory signal that leads 
to heightened ROS production in this manner. Because ursolic acid is lipophilic 
and structurally resembles cholesterol naturally imbedded in lipid rafts, it may 
replace some of the cholesterol in rafts. This substitution would impose 
structural changes to the cellular membranes and lipid rafts that may prevent 
nSMase activation and interrupt functional assembly of NOX. Throughout the 
study we found that the depletion of cholesterol by MBCD caused changes in 
lipid raft densities comparable to ursolic acid. Further research will determine the 
occurrence of cholesterol displacement and density when cells are exposed to 
ursolic acid.
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6.4 Cerebellar Neurons Generate High Levels of ROS
In contrast to other neurons, cerebellar neurons were found to generate 
the highest levels of ROS at rest and in response to ethanol and TNFa (Fig 5.10 
and Fig 5.11). The cerebellum may be more metabolically active than the other 
areas tested and therefore require more oxygen for biological processes, hence 
more oxygen radical byproducts. The health of the surrounding glia, particularly 
the astrocytes, is paramount to protecting the cerebellum from oxidative damage.
6.5 Astrocytes Protect Neurons from Oxidative Stress
The glia culture, positively marked for astrocytes, was found to display 
markedly increased antioxidant capacity (Fig 5.16) and a significantly lower ROS 
generation in response to physiological levels of ethanol (Fig 5.13). We also 
found that both architecture (GFAP labeling) and DNA (Hoechst labeling) of the 
glia culture were less impacted by ethanol and TNFa than that of cerebellar 
neurons (NF and Hoechst labeling), Fig 5.7 and Fig 5.9. The importance of glia, 
often ignored in neurological studies, should not be understated.
6.6 Cerebellar Neurons are Particular Sensitive to Alcohol
The results presented in this study point to a particular susceptibility of the 
cerebellar Purkinje neurons to alcohol during embryonic development. Since 
Purkinje neurons were grown in a heterogenous cerebellar cell culture, we were 
able to investigate the structural demise of Purkinje neurons (Cal labeling) as
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well as generic cerebellar neurons (NF labeling) in culture. It is clear that 
neurofilament and Purkinje specific cytoskeleton densities declined prior to DNA 
damage (Hoechst labeling, Fig 5.7) and metabolic decline (MTT viability assays, 
Fig 5.4). Consequently, it is no surprise that neuronal dysfunction precedes the 
cellular death and anatomical changes observed in clinical studies (Sullivan 
2000, Sullivan et al. 2000a, Sullivan et al. 2000b, Sullivan et al. 2006). It is 
imperative to improve therapies for individuals suffering from neuroinflammatory 
disease and alcoholism before they suffer irreparable brain damage.
Alcohol abuse leads to a sustained elevation of inflammatory TNFa in the 
brain comparable to levels found in end-stage neurodegenerative disease. Our 
research confirms that alcohol increases inflammation in part through stimulating 
TNFa secretion. Therefore, interventions that prevent heightened TNFa may 
ameliorate neurological symptoms caused by a myriad of neuroinflammatory and 
neurodegenerative diseases. In this study we tested the effectiveness of 
blueberry treatments against inflammatory insult by both ethanol and TNFa. We 
discovered that 35mM ethanol (0.16 BAC) and 200ng/ml TNFa (end-stage 
neurodegenerative disease) inflict similar damage to neurons as measured by 
cellular viability, ROS production, antioxidant capacity, lipid raft density, and lipid 
peroxidation. We report complete reversal of this damage through blueberry 
supplementation.
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6.7 Blueberry Biomolecules may Reverse Neuroinflammation
Most commonly individuals seek medical treatment after a problem has 
developed rather than initiating preventive measures. Encouraging data from 
this study not only supports the idea of blueberry supplementation in preventive 
medicine, but also the more realistic therapeutic supplementation of BBX and 
UA. If blueberry extracts are taken after neuroinflammatory insult (ethanol or 
TNFa) has occurred, they may rescue neurons and glia from death and prevent 
permanent damage to the brain. Within the time-frame applied to this study, we 
believe blueberry extracts and ursolic acid accomplished this very thing. Our 
data provides a thorough picture of the devastating effects of ethanol and TNFa 
on metabolic viability, cellular morphology, ROS generation, lipid peroxidation, 
TNFa secretion, lipid rafts, and sodium ion channels. In all cases, it was found 
that the initial detrimental effects of oxidative stress could be reversed through 
blueberry supplementation.
6.8 BBX and UA Enhance Cell Viability
Not only did blueberries protect neurons from oxidative stress, but BBX 
and UA also increased cellular viability. Immunofluorescent assays indicated a 
significant increase in neuronal neurofilaments (Fig 5.6) and glial GFAP (Fig 5.8) 
as a result of supplementation. This enhanced architecture is observed in 
conjunction with increased metabolic viability (Fig 5.4 and Fig 5.5). Therefore, 
our in vitro study is consistent with popular in vivo studies supporting
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enhancement of brain health via blueberry supplementation (Youdim et al. 2000, 
Joseph et al. 1999). We believe wild Alaskan blueberries will provide even 
stronger therapies than berries grown at lower latitudes due to their significantly 
increased antioxidant composition (Flint and Robinson 2011). Our research 
found the total antioxidant power of wild Alaskan berries (grown in the Interior), to 
be three times more powerful than the average cultivated berry of the continental 
United States (Haytowitz and Bhagwat 2010).
6.9 Sodium ion Channel Localization is Altered by Alcohol
For the first time, the relevance of sodium ion channel localization to lipid 
rafts and possible modifications due to alcohol exposure was investigated. Our 
findings lead us to conclude that inflammation has a drastic impact on the density 
of sodium ion channels found in the membranes collocated with lipid rafts. 
Blueberry supplementation may minimize this effect by preventing large 
coalescence of lipid rafts. As we have previously discussed, large lipid raft 
signaling platforms host assembly of ROS generating enzymes that create an 
oxidative environment. When left unchecked, densities of these enzymes, lipid 
rafts, and Nav channels remain high and lead to a chronic inflammatory state. It 
is unknown how this increase in Nav channels manifests clinically, however the 
high occurrence of epileptic seizures (Nav disorder) observed in alcoholics yields 
important clues (Frucht et al. 2000).
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The embryonic chick proved to be an excellent and economical means to 
establish comparative cellular research between different regions of the brain 
and peripheral nervous system. It could likewise be utilized to examine 
morphological and electrophysiological changes in the brain during embryonic 
development. The results presented in this study will advance our understanding 
of the neuroinflammatory effects of alcohol and provide a novel nutritional 
approach to improve the overall health of alcoholics and unborn babies subject to 
maternal alcohol abuse.
Blueberries and ursolic acid present raw materials for further medical 
research and therapies targeted at inflammatory and neurodegenerative disease. 
Studies addressing the bioavailability of blueberry metabolites in the bloodstream 
and their ability to cross the BBB are logical steps to pursue in animal models as 
well as in humans. Strong efforts will be made to communicate our findings 
with health care professionals and medical researchers to bridge the gap 
between scientific discovery, education and patient care.
118
6.10 Future Directions
Chapter 7: References
Abele M, Riet A, Hummel T, Klockgether T, Wullner U (2003). Olfactory 
dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol 250: 
1453-1455.
Afshari FS, Ptak K, Khaliq ZM, Grieco TM, Slater NT, McCrimmon DR & Raman 
IM (2004). Resurgent Na currents in four classes of neurons of the cerebellum.
J Neurophysiol 92:2831-2843.
Andres-Lacueva C, Shukitt-Hale B, Galli R, Jauregui O, Lamuela-Raventos R, 
Joseph J (2005). Anthocyanins in aged blueberry-fed rats are found centrally 
and may enhance memory. Nutr Neurosci 10: 111-120.
Baker K, Harding A, Halliday G, Kril J, Harper C (1999). Neuronal loss in 
functional zones of the cerebellum of chronic alcoholics with and without 
Wernicke's encephalopathy. J Neurosci 91:429-438.
Baptista CA, Hatten ME, Blazeski R, Mason CA(1994). Cell-cell interactions 
influence survival and differentiation of purified Purkinje cells in vitro. Neuron 12: 
243-260.
119
120
Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H
(2003). Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer’s 
disease and vascular dementia. Neurobiol Aging 24: 333-338.
Beal (1995). Aging, Energy, and Oxidative Stress in Neurodegenerative 
Diseases. Ann Neurol 38: 357-366.
Bean BP (2005). The Molecular Machinery of Resurgent Sodium Current 
Revealed. Neuron 45(2): 185-187.
Bellairs R, Osmond M (2005). The Atlas of Chick Development. Elsevier 
Academic Press, San Deigo, CA.
Black JA, Renganathan M & Waxman SG (2002). Sodium channel Nav1.6 is 
expressed along nonmyelinated axons and it contributes to conduction. Mol 
Brain Res 105: 19-28.
Blanco A, Valles S, Pascual M, Guerri C (2006). Involvement of TLR4/Type I IL-1 
Receptor Signaling in the Induction of Inflammatory Mediators and Cell Death 
Induced by Ethanol in Cultured Astrocytes. The Journal of Immunology 175: 
6893-6899.
Brieskorn CHZ, Klinger H (1961). Uber das gemeinsame Vorkommen von 
Triterpenen und Sterinen im Blatt von Salvia triloba und Pirus malus: Mitteilung 
zur Kenntnis der Biochemie der Triterpene. Archiv der Pharmazie 294(7): 389­
391.
Caldwell JH, Schaller L, Lasher RS, Peles E, Levinson SR (2000). Sodium 
channel Navi .6 is localized at nodes of Ranvier, dendrites, and synapsis. PNAS 
97: 5616-5620.
Cazzaniga E, Bulbarelli A, Masserini M (2010). Alcohol and Neural Lipids. Eds: 
Lajtha A, Tettamanti G, Goracci G. Handbook of Neurochemistry and Molecular 
Neurobiology. 503-515.
Chin JH, Parsons LM, Goldstein DB (1978). Increased cholesterol content of 
erythrocyte and brain membranes in ethanol-tolerant mice. Biochim Biophys 
Acta 513(3): 358-63.
Chung HJ, Steinberg JP, Huganir RL, Linden, DJ (2003). Requirement of AMPA 
receptor GluR2 phosphorylation for cerebellar long-term depression. Science 
300: 1751-1755.
121
Clark BA, Monsivais P, Branco T, London M, Hausser M (2005). The site of 
action potential initiation in cerebellar Purkinje neurons. Nat Neurosci 8: 137— 
139.
Connelly T, Farmer JM, Lynch DR, Doty RL (2003). Olfactory dysfunction in 
degenerative ataxias. J Neurol Neurosurg Psychiatry 74:1435-1437.
Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo 
G, Wheeler M, Zou J (2006). Cytokines and Alcohol. Alcoholism: Clin and Exp 
Res 30: 720-730.
Crews FT, Nixon K (2009). Mechanisms of neurodegeneration and regeneration 
in alcoholism. Alcohol Alcohol. 44(2): 115-27.
Cummins TR, Dib-Hajj SD, Herzog Rl and Waxman SG (2005). Nav1.6 channels 
generate resurgent sodium currents in spinal sensory neurons. FEBS Lett 579: 
2166-2170.
Dai Q, Zhang J, Pruett SB (2005). Ethanol alters cellular activation and CD14 
partitioning in lipid rafts. Biochem Biophys Res Commun 33: 37-42.
122
de Queiroz GM, de Souza MM, de Carvalho TC, Casemiro LA, Cunha WR, 
Martins CH (2011). Absence of the antibacterial activity of the crude extracts and 
compounds isolated from M. rubiginosa against extended-spectrum p-lactamase 
producing enterobacteria. J Pharm Negative Results 2: 1-7.
Dick DJ, Boakes RJ, Harris JB (1985). A cerebellar abnormality in the mouse 
with motor end-plate disease. Neuropathol Appl Neurobiol 11: 141-147.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL 
(2010). A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5): 
446-457.
Dringen R, Gutterer R, and Hirrlinger J (2000). Glutathione metabolism in brain - 
Metabolic interaction between astrocytes and neurons in the defense against 
reactive oxygen species. EurJBiochem  267:4912-4916.
Ehrlander M (2010). The Historical Roots of a Frontier Alcohol Culture: Alaska 
and Northern Canada. The Northern Review 32: 63-103.
Erlanger J, Blair EA (1938). Comparative observations on motor and sensory 
fibers with special reference to repetitiousness. Amer J Physiol 121: 431-453.
123
Feirabend HKP (1990). Development of longitudinal patterns in cerebellum of 
the chick Gallus domesticus: A cytoarchitectural study on the genesis of 
cerebellar modules. Eur J Morphol 28: 169-223.
Feirabend HKP, Van Luxemburg EA, Van Dnederen- Van Dorp H, Voogd J 
(1985). A 3H-thymidime autoradiographic study of the development of the 
cerebellum of the white leghorn (Gallus domesticus): Evidence for longitudinal 
neuroblast generation patterns. Acta Morphol Neerl Scand 23: 115-126.
Fenaughty A, Fink K, Peck D, Wells R, Utermohle C, Peterson E (2009). The 
Burden of Overweight and Obesity in Alaska, Summary Report. Anchorage, AK: 
Section of Chronic Disease Prevention and Health Promotion, Division of Public 
Health, Alaska Department of Health and Social Services.
Fernandez-Lizarbe S, Pascual M, Soledad Gascon M, Blanco A, Guerri C (2007). 
Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine 
macrophages. Molecular Immunology 45: 2007-2016.
Flint C, Robinson E (2011). Promoting Wellness in Alaskan Villages: Integrating 
Traditional Knowledge and Science of Wild Berries. Eco Health 8(2): 199-209.
Frank-Cannon T, Alto L, McAlpine F, Tansey M (2009). Does neuroinflammation 
fan the flame in neurodegenerative diseases? Mol Neurodegener 4: 47.
124
Frucht M, Quigg M, Schwaner C, Fountain N (2000). Distribution of Seizure 
Precipitants Among Epilepsy Syndromes. Epilepsia 41: 1534-1539.
Ghez C, Fahn S, and edited by Kandel ER and Schwartz JH (1985). The 
cerebellum. Principles of Neural Science, 2nd edition, New York, Elsevier 502­
522.
Gil-Mohapel J, Boehmea F, Kainera L, Christiea B (2010). Hippocampal cell loss 
and neurogenesis after fetal alcohol exposure: Insights from different rodent 
models. Brain Research Reviews 64: 283-303.
Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, Tchetchik D, Eliseenkova 
A, Xu C, Neubert T, Ornitz D, Goldfarb M, Mohammadi M (2009). Crystal 
Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a 
Conserved Surface on FHFs for Binding and Modulation of Voltage-gated 
Sodium Channels. J Biol Chem 284: 17883-17896.
Goldin AL (2001). Resurgence of sodium channel research. Annu Rev Physiol 
63:871-894.
Gustafson S, Dunlap K, McGill C, Kuhn T. A nonpolar blueberry fraction blunts 
NADPH oxidase activation in neuronal cells exposed to tumor necrosis factor 
alpha. Oxidative Medicine and Cellular Longevity. (2012), In Press.
125
Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H 
(2007). Olfactory Loss May Be a First Sign of Idiopathic Parkinson’s Disease. 
Movement Disorders: 22(6): 839-842.
Han W, Li H, Villar VA, Pascua AM, Dajani Ml, Wang X, Natarajan A, Quinn MT, 
Felder RA, Jose PA, Yu P (2008). Lipid rafts keep NADPH oxidase in the inactive 
state in human renal proximal tubule cells. Hypertension 51: 481-487.
Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, 
Persidsky Y (2005a). Ethanol-induced activation of myosin light chain kinase 
leads to dysfunction of tight junctions and blood-brain barrier compromise. 
Alcohol Clin Exp Res 29: 999-1009.
Haorah J, Knipe B, Leibhart J, Ghorpade A, Persidsky Y (2005b). Alcohol- 
induced oxidative stress in brain endothelial cells causes blood-brain barrier 
dysfunction. J Leukoc Biol 78: 1223-1232.
Haorah J, Knipe B, Gorantla S, Zheng J, Persidsky Y (2007). Alcohol-induced 
blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate 
receptor (IP3R)-gated intracellular calcium release. Journal of Neurochemistry 
100: 324-336.
126
Harder T, Engelhardt K (2004). Membrane Domains in Lymphocytes -  From 
Lipid Rafts to Protein Scaffolds. Traffic 5: 265-275.
Haytowitz D, Bhagwat S (2010). USDA Database for the Oxygen Radical 
Absorbance Capacity (ORAC) of Selected Foods, Release 2. Nutrient Data 
Laboratory, BHNRC, ARS, USDA.
Hibbeln JR, Salem Jr N (1995). Dietary polyunsaturated fatty acids and 
depression: when cholesterol does not satisfy. Am J Clin Nutr 62(1): 1-9.
Hong S, Wiley JW (2006). Altered expression and function of sodium channels 
in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the 
rat. Biochem and Biophys Res Comm 339(2): 652-660.
Jenkins SM, Bennett V (2001). Ankyrin-G coordinates assembly of the spectrin- 
based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at 
Purkinje neuron initial segments. J Cell Biol 155: 739-746.
Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, 
Bickford PC (1999). Reversal of age-related declines in neuronal signal 
transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or 
strawberry dietary supplementation. J Neurosci 19(18): 8114-21.
127
Kaplan M, Cho M, Ullian E, Isom L, Levinson S, Barres B (2001). Differential 
Control of Clustering of the Sodium Channels Navi .2 and Navi .6 at Developing 
CNS Nodes of Ranvier. Neuron 30: 105-119.
Kearney JA, Buchner DA, De Haan G, Adamska M, Levin SI, Furay AR, Albin 
RL, Jones JM, Montal M, Stevens MJ, Sprunger LK, Meisler MH (2002). 
Molecular and pathological effects of a modifier gene on deficiency of the sodium 
channel Scn8a (Na(v)1. 6). Hum Mol Genet 11: 2765-2775.
Klopfenstein DR, Tomishige M, Stuurman N and Vale RD (2002). Role 
ofphosphatidylinositol(4,5)bisphosphate organization in membrane transport by 
the Unci 04 kinesin motor. Cell 109: 347-58.
Kohrman DC, Smith MR, Goldin AL, Harris J, Meisler MH (1996). A Missense 
Mutation in the Sodium Channel Scn8a Is Responsible for Cerebellar Ataxia in 
the Mouse Mutant jolting. J Neurosci 16(19): 5993-5999.
Lau F, Shukitt-Hale B, Joseph J (2007). Nutritional Intervention in Brain Aging. 
Inflammation in the Pathogenesis of Chronic Diseases 14: 299-318.
Le Bel CP, Odunze IN, Adams JD, Bondy SC (1989). Brain formation and 
membrane order following vitamin E deficiency. Biochem Biophys Res Commun 
163: 860-6.
128
Li Q, Spencer NY, Oakley FD, Buettner JR, Engelhardt JF (2009). Endosomal 
Nox2 Facilitates Redox-Dependent Induction of NF-kB by TNFa. Antioxidants & 
Redox Signaling 11 (6): 1249-1263.
Liu B, Gao H-M, Hong J-A (2003). Parkinson's disease and exposure to 
infectious agents and pesticides and the occurrence of brain injuries: role of 
neuroinflammation. Enviro Health Perspec 111(8): 1065-1073.
Liu, J (1995). Pharmacology of oleanolic acid and ursolic acid. J Ethnopharm 
49(2): 57-68.
Locksley RM, Killeen N, Lenardo MJ (2001). The TNFa and TNFa receptor 
superfamilies: integrating mammalian biology. Cell 104 (4): 487-501.
Lou JY, Laezza F, Gerber BR, Xiao M, Yamada KA, Hartmann H, Craig AM, 
Nerbonne JM, Ornitz DM (2005). Fibroblast growth factor 14 is an intracellular 
modulator of voltage-gated sodium channels. J Physiol (Lond) 569: 179-193.
Lu J, Zheng Y-L (2007). Ursolic acid ameliorates cognition deficits and 
attenuates oxidative damage in the brain of senescent mice induced by d- 
galactose. Biochem Pharm 74(7): 1078-1090.
129
Mahadik S, Evans D, Lai H (2001). Oxidative Stress and Role of Antioxidant and 
omega-3 essential fatty acid supplementation in schizophrenia. Pro Neuro- 
Psychoparmacol & Bio Psychiat 25: 463-493.
Meisler MH, Kearney JA (2005). Sodium channel mutations in epilepsy and 
other neurological disorders. J Clin Invest 115(8): 2010-2017.
Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M 
(2005). Oxidation and carboxyl methyl lysine modification of albumin: possible 
involvement in the progression of oxidative stress in hemodialysis patients. 
Hypertens Res 28: 973-980.
Meydani M, Macauley JB, Blumberg JB (1986). Influence of dietary vitamin E, 
selenium and age on regional distribution of alpha-tocopherol in the rat brain. 
Lipids 21(12): 786-91.
Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR
(2005). Cross-linking of the extracellular matrix by the maillard reaction in aging 
and diabetes: an update on “a puzzle nearing resolution”. Ann NY Acad Sci 
1043: 533-544.
130
Nimmerjahn A, Kirchohoff F, Helmchen F (2005). Resting Microglial Cells are 
Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science 27: 1314­
1318.
Nordin S, Monsch AU, Murphy C (1995). Unawareness of smell loss in normal 
and Alzheimer's disease: discrepancy between self-reported and diagnosed 
smell sensitivity. Journal of Gerontology 50(4): 187-92.
Nordmann R, Ribiere C, Rouach H (1990a). Ethanol-Induced Lipid Peroxidation 
and Oxidative Stress in Extrahepatic Tissues. Alcohol and Alcoholism 25(2-3): 
231-237.
Nordmann R, Rouach H, Houze P (1990b). Alcohol, iron and oxidative stress. 
Bull Acad Natl Med 174 (1): 95-102.
Opreanu M, Lydic T, Reid G, McSorley K, Esselman W, and Busik J (2010). 
Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through 
Downregulation of Sphingomyelinases by Docosahexaenoic Acid. Retinal Cell 
Bio 51: 3253-63.
Orban N, Kozak IO (2009). LC-MS method development to evaluate major 
triterpenes in skins and cuticular waxes of grape berries. Internat J Food Sci & 
Tech 44(4): 869-873.
131
Pan F, Beam KG (1999). The absence of resurgent sodium current in mouse 
spinal neurons. Brain Res 849: 162-168.
Pawlosky R, Bacher R, Salem Jr R (2001). Ethanol Consumption Alters 
Electroretinograms and Depletes Neural Tissues of Docosahexaenoic Acid in 
Rhesus Monkeys: Nutritional Consequences of a Low Omega-3 Fatty Acid Diet. 
Alcohol Clin Exp Res 25(12): 1758-1765.
Peles E, Salzer JL (2000). Molecular domains of myelinated axons. Curr Opin 
Neurobiol 10: 558-565.
Peoples RW, Weight FF (1997). Anesthetic actions on excitatory amino acid 
receptors. Anesthesia: Biologic Foundations (Biebuyck JF, Lynch C, Maze M, 
Saidman LJ, Yaksh Tl, Zapol WM, eds.) Lippincott-Raven, NY 239-258.
Pietrzykowski A, Treistman S (2008). The Molecular Basis of Tolerance.
Alcohol Research and Health 31: 298-309.
Qin L, He J, Hanes R, Pluzarev O, Hong JS, Crews FT (2008). Increased 
systemic and brain cytokine production and neuroinflammation by endotoxin 
following ethanol treatment. J Neuroinflam 5: 10.
132
Raivich G (2005). Like cops on the beat: the active role of resting microglia. 
Trends in Neurosci 28: 571-573.
Raman IM, Bean BP (1997). Resurgent sodium current and action potential 
formation in dissociated cerebellar Purkinje neurons. J Neurosci 17: 4517­
4526.
Raman IM, Sprunger LK, Meisler MH, Bean BP (1997). Altered subthreshold 
sodium currents and disrupted firing patterns in Purkinje neurons of SCN8a 
mutant mice. Neuron 19: 881-891.
Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, 
Debsikdar VB, Mahadik SP (2003). Decreased antioxidant enzymes and 
membrane essential polyunsaturated fatty acids in schizophrenic and bipolar 
mood disorder patients. Psychiatry Res 121: 109-122.
Rapoport M, van Reekum R, Mayberg H (2000). The Role of the Cerebellum in 
Cognition and Behavior: A Selective Review. J Neuropsyc & Clin Neurosci 12: 
193-198.
Reddy VP, Beyaz A (2006). Inhibitors of the Maillard reaction and AGE breakers 
as therapeutics for multiple diseases. Drug Discovery Today 11: 646-654.
133
134
Riikonen J, Jaatinen P, Rintala J, Porsti I, Karjala K, Hervonen A (2002). 
Intermittent ethanol exposure increases the number of cerebellar microglia. 
Alcohol 37(5): 421-6.
Rivest S (2009). Regulation of innate immune reponses in the brain. Nature Rev 
Immun 9: 429-439.
Rupp C, Kurz M, Kemmler G, Mair D, Hausmann A, Hinterhuber H,
Fleischhacker WW (2003). Reduced Olfactory Sensitivity, Discrimination, and 
Identification in Patients with Alcohol Dependence. Alcohol Clin Exp Res 27(3): 
432-439.
Saraswat B, Visen PKS, Agarwal DP (2000). Ursolic acid isolated from 
Eucalyptus tereticornis protects against ethanol toxicity in isolated rat 
hepatocytes. Phytother Res 14: 163-166.
Saravanan R, Pugalendi V (2006). Impact of ursolic acid on chronic ethanol- 
induced oxidative stress in the rat heart. Pharmalogical Reports 58: 41-47.
Saravanan R, Viswanathan B, Pugalendi, KV (2006). Protective effect of ursolic 
acid on ethanol-mediated experimental liver damage in rats. Life Sciences 78: 
713-718.
Schaller KL, Caldwell JH (2000). Developmental and regional expression of 
sodium channel isoform NaCh6 in the rat central nervous system. J Comp Neurol 
420: 84 -97.
Schaller KL, Caldwell JH (2003). Expression and distribution of voltage-gated
sodium channels in the cerebellum. Cerebellum 2: 2-9.
Schmahmann JD (2004). Disorders of the cerebellum: ataxia, dysmetria of 
thought, and the cerebellar cognitive affective syndrome. J Neuropsych Clin 
Neurosci 16: 367-78.
Schmahmann JD, Caplan D (2006). Cognition, emotion and the cerebellum. 
Commentary on Brain 129: 306-320 and Brain 129: 290-2.
Schmidt K, Martinez-Gamboa L, Meier S, Witt C, Meisel C, Hanitsch LG,
Becker MO, Huscher D, Burmester GR, Riemekasten G (2009).
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and 
predictors for the outcome of interstitial lung disease in systemic sclerosis 
patients. Arth Res & Ther 11: 111.
Schneider P, Hosseiny SS, Szczotka M, Jordan M, Schlitter K (2009). Rapid 
solubility determination of the triterpenes oleanolic acid and ursolic acid by UV- 
spectroscopy in different solvents. Phytochem Let 2(2): 85-87.
135
Seis H (1991). Oxidative stress: from basic research to clinical application.
Am J Med 91: 31-38.
Shih Y, Chein Y, Wang J, Fu Y (2004). Ursolic Acid protects hippocampal 
neurons against kainite induced excitotoxicity in rats. Neurosci Lett 362(2): 
136-140.
Simons K, Toomre E (2000). Lipid rafts and signal transduction. Nat Rev Mol 
Cell Biol 1: 31-39.
Stamatovic S, Keep R, Andjelkovic A (2008) Brain endothelial cell-cell junctions: 
howto "open" the blood brain barrier. Curr Neuropharmacol 6(3): 179-92.
Stillwell W, Shaikh SR, Zeoruga M, Siddiqui R, Wassail SR (2005). 
Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr 
Dev 45: 559-579.
Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassail SR (2006). 
Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr 
Dev 45(5): 559-79.
136
Sullivan EV (2000). Human brain vulnerability to alcoholism: evidence from 
neuroimaging studies. In: Noronha A, Eckardt M, Warren K (eds). Review of 
NIAAA's Neuroscience and Behavioral Research Portfolio NIAAA Research 
Monograph No. 34. National Institutes of Health: Bethesda, MD. pp 473-508.
Sullivan EV, Adalsteinsson E, Sood R, Mayer D, Bell RL, McBride WJ et al
(2006). Part I: longitudinal brain MRI brain study of the alcohol-preferring (P) rat: 
adult brain growth. Alcohol Clin Exp Res 30: 1234-1247.
Sullivan EV, Deshmukh A, Desmond JE, Lim KO, Pfefferbaum A (2000a). 
Cerebellar volume decline in normal aging, alcoholism, and Korsakoffs 
syndrome: relation to ataxia. Neuropsych 14: 341-352.
Sullivan EV, Deshmukh A, Desmond JE, Mathalon DH, Rosenbloom MJ, Lim KO 
et al (2000b). Contribution of alcohol abuse to cerebellar volume deficits in men 
with schizophrenia. Arch Gen Psych 57: 894-902.
Sun GY, Sun AY (1985). Ethanol and membrane lipids. Alcohol Clin Exp Res 
9(2): 164-80.
Sun A, Simonyi A, Sun G (2002). The “French Paradox” and beyond: 
neuroprotective effects of polyphenols. Free Rad Bio & Med 32(4): 314-318.
137
Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N 
(2010). A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68 
(10): 930-941.
Szabo G (1997). Alcohol’s Contribution to Comprised Immunity. Alcohol Health 
and Res World 21: 30-41.
Szabo G, Dolganiuc A, Dai Q, Pruett SB (2007). TLR4, ethanol, and lipid rafts: a 
new mechanism of ethanol action with implications for other receptor mediated 
effects. J Immunol 178 (3): 1243-1249.
Szic KS, Ndlovu MN, Haegeman G, Vanden Berghe W (2010). Nature or 
nurture: let food be your epigenetic medicine in chronic inflammatory disorders. 
Epigenetics 15;80(12): 1816-32.
Tansey MG, Wyss-Coray T (2008). Cytokines in CNS inflammation and disease. 
In: Lane TE, Carson M, Bergmann C, Wyss-Coray T (eds). Central nervous 
system diseases and inflammation, 1st edn. Springer, New York, pp 59-106.
Tansey MG, McCoy MK, Frank-Cannon TC (2007). Neuroinflammatory 
mechanisms in Parkinson’s disease: potential environmental triggers, pathways, 
and targets for early therapeutic intervention. Exp Neurol 208: 1 -25.
138
Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE (2006). Chronic 
ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in 
rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 
activation and TNFa production. J Leukoc Biol 79(6): 1348-56.
Trudeau M, Dalton J, Day J, Ranum L, Meisler M (2006). Heterozygosity for a 
protein truncation mutation of sodium channel SCN8A in a patient with cerebellar 
atrophy, ataxia, and mental retardation. J Med Genet 43: 527-530.
Tyrrell T and Willshaw D (1992). Cerebellar cortex: its simulation and the 
relevance of Marr's theory. Philosophical transactions of the Royal Society of 
London, Series B, Biological sciences 336(1277): 239-57.
Valles S, Blanco A, Pascual M, Guerri C (2004). Chronic ethanol treatment 
enhances inflammatory mediators and cell death in the brain and in astrocytes. 
Brain Pathol 14: 365-371.
Vasdev S, Gill V, Singal P (2006). Beneficial effect of low ethanol intake on the 
cardiovascular system: possible biochemical mechanisms. Vascular Health and 
Risk Management 2(3): 263-276.
139
Vilhardt F, Van Deurs B (2004). The phagocyte NADPH oxidase depends on 
cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739­
48.
Wadiche Jl, Jahr CE (2001). Multivesicular release at climbing fiber-Purkinje 
cell synapses. Neuron 32(2): 301-13.
Weiss N, Miller F, Cazaubon S, Couraud PO (2009). The blood-brain barrier in 
brain homeostasis and neurological diseases. Biochem Biophys Acta 1788(4): 
842-57.
Wheeler D, Knapp E, Bandaru W R , Wang Y, Knorr D, Poirier C, Mattson MP, 
Geiger JD, Haughey NJ (2009). Tumor necrosis factor-alpha-induced neutral 
sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane 
insertion of NMDA receptors. J Neurochem 109(5): 1237-1249.
Wilson JX (1997). Antioxidant defense of the brain: a role for astrocytes. Can J 
Physiol Pharmacol 75(10-11): 1149-63.
Wittmack EK, Rush AM, Craner MJ, Goldfarb M, Waxman SG, Dib-Hajj SD
(2004). Fibroblast growth factor homologous factor 2B: association with Navi .6 
and selective colocalization at nodes of Ranvier of dorsal root axons. J Neurosci 
24: 6765- 6775.
140
Yang B, Rizzo V (2007). TNFa potentiates protein-tyrosine nitration through 
activation of NADPH oxidase and eNOS localized in membrane rafts and 
caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: 
H954-62.
Yin MC, Chan KC (2007). Nonenzymatic Antioxidative and Antiglycative Effects 
of Oleanolic Acid and Ursolic Acid. J Agric Food Chem 55: 7177-7181.
Youdim KA, Shukitt-Hale B, MacKinnon S, Kalt W, Joseph JA (2000). 
Polyphenolics enhance red blood cell reistance to oxidative stress: in vitro and in 
vivo. Biochem Biophys Acta 1523(1): 117-22.
Youdim K, Spencer J, Schroeter H, Rice-Evans C (2002). Dietary flavonoids as 
potential neuroprotectants. Biol Chem 383: 205-231.
Zaleska M, Nagy K, Floyd RA (1989). Iron-induced lipid peroxidation and 
inhibition of dopamine synthesis in striatum synaptosomes. Neurochem Res 
14(7): 597-605.
Zhou DS, Lambert PL, Malen S, Carpenter LM, Boland, Bennett V (1998). 
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial 
segments and for normal action potential firing. J Cell Biol 143: 1295-1304.
141
Appendix A: Additional Figures
142
1400
1200
e
H 1000o
Q,
O)
a>
£
ow
£c3
5=
800
600
400
200
Pre- and Post-Treatments
Fig A.1 Immediate ROS Generation in Human SH-SY5Y Neuroblastoma 
Cells - ROS is reported as a measure of fluorescent output at 535 nm per 
microgram of protein sampled taken at 45 minutes (after pretreatments) and at 
90 minutes (after pre- and post-treatments are complete). Cerebellar neuronal 
cultures were held for 45 minutes under different conditions. Columns NT 
through UA had the same pre- and post-treatments and the remaining columns 
were pretreated with 5ug/ml BBX, 5ug/ml NP, 5ug/ml UA, 200ng/ml TNFa (IQ- 
12). Pretreatments were rinsed and post-treatments were added for another 45 
minutes: no treatment (NT), 1mM H2O2 , 200ng/ml TNFa, 5ug/ml BBX, 5ug/ml 
NP, 5ug/ml UA, 200ng/ml TNFa (7-9), 5ug/ml BBX, 5ug/ml NP, and 5ug/ml UA. 
Values are reported as P< 0.05 where “a” indicates decreased ROS generation 
compared to “A”. ROS was decreased at 90 minutes ( x ) by BBX, NP; and UA 
compared to 45 minutes. Treatments identified with ( * ) increased ROS 
compared to NT.
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Fig A.2 Immediate ROS Generation in Forebrain Cortical Neurons
ROS is reported as a measure of fluorescent output at 535 nm per microgram of 
protein sampled taken at 45 minutes (after pretreatments) and at 90 minutes 
(after pre- and post-treatments are complete). Forebrain cortical neuron cultures 
were held for 45 minutes under different conditions. The first six columns had 
the same pre- and post-treatments and the remaining columns were pretreated 
with 5ua/ml BBX. 5ua/ml NP. 5ua/ml UA. 200na/ml TNFa (10-12). Pretreatments 
were rinsed and post-treatments were added for another 45 minutes: no 
treatment (NT), 1mM H20 2i 200ng/ml TNFa, 5ug/ml BBX, 5ug/mi NPf 5ug/ml UA, 
2Q0ng/ml TNFa (7-9), 5ug/ml BBX, 5ug/ml NP, and 5ug/ml UA. Values are 
reported as P< 0.05 where “a” indicates decreased ROS generation compared to 
“A”. ROS was decreased at 90 minutes ( x ) by BBX, NP and UA compared to 
45 minutes. BBX** is significantly lower than NT while ( * ) is higher.
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Fig A.3 Immediate ROS Generation in Spinal Neurons
ROS is reported as a measure of fluorescent output at 535 nm per microgram of 
protein sampled taken at 45 minutes (after pretreatments) and at 90 minutes 
(after pre- and post-treatments are complete). Spinal cultures were held for 45 
minutes under different conditions. Columns 1-6 had the same pre- and post­
treatments and the remaining columns were pretreated with 5ug/ml BBX, 5ug/ml 
NP. 5ua/ml UA. 200na/ml TNFa (10-12). Pretreatments were rinsed and Dost- 
treatments were added for another 45 minutes: no treatment (NT), 1mM H2O2, 
200ng/ml TNFa, 5ug/ml BBX, 5ug/ml NP, 5ug/ml UA, 200ng/ml TNFa (7-9), 
5ug/ml BBX, 5ug/ml NP, and 5ug/ml UA. Values are reported as P< 0.05 where 
“a” indicates decreased ROS generation compared to “A ', ROS was decreased 
at 90 minutes ( x ) by BBX, NP, and UA compared to 45 minutes. BBX** is 
significantly lower than NT while ( * ) is higher.
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Fig A.4 Immediate ROS Generation in DRG Neurons
ROS is reported as a measure of fluorescent output at 535 nm per microgram of 
protein sampled taken at 45 minutes (after pretreatments) and at 90 minutes 
(after pre- and post-treatments are complete). DRG neuronal cultures were held 
for 45 minutes under different conditions. Columns 1-6 had the same pre- and 
post-treatments and the remaining lanes were pretreated with 5ug/ml BBX, 
5ug/ml NP 5ug/ml UA, 200ng/ml TNFa (10-12). Pretreatments were rinsed and 
post-treatments were added for another 45 minutes: no treatment (NT), 1mM 
H20 2, 200ng/ml TNFa, 5ug/ml BBX, 5ug/ml NPt 5ug/ml UA, 200ng/ml TNFa (7­
9), 5ug/ml BBX, 5ug/ml NP, and 5ug/ml UA. Values are reported as P< 0.05 
where “a” indicates decreased ROS generation compared to “A”. ROS was 
decreased at 90 minutes ( x ) by BBX, NP, and UA compared to 45 minutes. 
Treatments identified with ( * ) increased ROS compared to NT.
ROS generation in neurons
Fig A.5 Comparative ROS Response of Neurons
ROS is reported at 48 hours as a measure of fluorescent output at 535 nm per microgram of protein sampled. 
Results were normalized to the negative control (NT). Columns 1-8 had the same pre- and post-treatments and 
were held in serum free media while the remaining columns were pretreated as indicated by the first treatment 
listed in each column. Pretreatments were rinsed after 24 hours and post-treatments were added for an 
additional 24 hours. Results for different neurons are presented as C-cortical forebrain (blue), Cb-cerebellum 
(red), DRG (green), S-spine (purple).
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Appendix B 
Additional Statistical Data
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Table B.2: Corresponds to Fig 5.5
CB (n=4) NT 1M H202 1mM H202 TNF E17 E35 E100 E200 NP NP+E200 E20C+NP NP+H202 H202+NP
AVG (norm) 1.000 0.134 0.699 0.719 1.382 1 167 0.923 0.468 1 375 1.078 0.986 1.085 1 158
SD (+/-) 0.007 0.008 0.032 0.039 0.001 0,003 0.030 0.068 0.023 0.159 0.027 0.005 0.006
DRG (n=4) NT 1M H202 1mM H202 TNF E17 E35 E100 E200 NP NP+E200 E20O+NP NP+H202 H202+NP
AVG (norm) 1 000 0.212 0.711 0.701 1.730 1,536 1.198 0.506 1.494 1.419 1.413 1.300 1.443
SD (+/-) 0.018 0.040 0.045 0.059 0.028 0.025 0.026 0.062 0.021 0.056 0.062 0.021 0.018
GLIA (n=4) NT 1M H202 1mM H202 TNF E17 E35 E100 E200 NP NP+E200 E200+NP NP+H202 H202+NF
AVG (norm) 1.000 0.297 1.230 2.064 2.826 2.921 2.541 0.855 2.824 2.804 2.876 2.155 2.667
SD (+/-) 0.219 0.062 0.253 0.124 0.065 0.113 0.449 0.082 0.059 0.106 0.373 0,282 0.074
Table B.3: Corresponds to Fig 5.6
NF (n=6) NT H202 TNF E35 BBX UA TNF+BBX TNF+UA BBX+TMF E35+BBX E35+UA BBX+E35
AVG (norm) 1.0000 0.6765 0.8479 0.8434 1.2985 1.3513 1.2809 1,2933 1.3940 1.1903 1,2936 1.3602
S D - ) 0.0520 0.0482 0.0567 0.0511 0.0486 0.0992 0.1197 0.1737 0.1637 0.0999 0.2352 0.0180
CAL (n=6) NT H202 TNF E35 BBX UA TNF+BBX TNF+UA BBX+TNF E35+BBX E35+UA BBX+E35
AVG (norm) 1.0000 0.6130 0.8124 0.8181 1.1471 1.1731 1.0192 1.0380 1.0388 1,0503 1,0109 1.0342
SD (+/•) 0.0611 0.1202 0.0976 0.1119 0.0444 0.0525 0.0436 0,0760 0.0500 0.0867 0,0670 0.0507
Hoechst (n=6) NT H202 TNF E35 BBX UA TNF+BBX TNF+UA BBX+TNF E35+BBX E35+UA BBX+E35
AVG (norm) 1.0000 0.6254 0.7711 0.8133 1.0000 0.9814 0.9770 0,8275 0.8809 0.8730 0,9208 1.0222
SD (+/-) 0.0300 0.0473 0.1155 0.0768 0,0741 0.0789 0,0953 0,1184 0.2071 0.0386 0.1738 0.1325
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Table B.4: Corresponds to Fig 5.7
N F (n=6) 0 17 .4 3 5 50 100 2 0 0 4 0 0
AVG (norm) 1.0000 0 .9117 0 .8197 0.7584 0.6080 0.3190 0.0991
SD (+/-) 0 .0140 0 .0455 0.0842 0.0728 0.0362 0.0432 0.0130
C AL (n=6) 0 17.4 35 50 100 2 0 0 4 0 0
AVG (norm) 1.0000 0.9741 0.9298 0.8623 0.7891 0.5725 0.2749
SD (+/-) 0 .0140 0.0598 0.0366 0.0554 0.0609 0.0392 0.1095
Hoechst (n=6) 0 17.4 3 5 50 100 2 0 0 4 0 0
AVG {norm) 1.0000 0.9731 0.963C 0.9307 0.8646 0.8280 0.6616
SD <+/-} 0 .0096 0 .0360 0.1125 0 .0784 0 .0752 0.0548 0.0574
Table B.5: Corresponds to Fig 5.8
GFAP (n=4) NT H202 TNF E35 BBX UA TNF+BBX TNF+UA BBX+TNF E35+BBX E35+UA BBX+E35
AVG (norm) 1.0000 0.7584 0.9953 0.8515 1.2597 1.1188 1.1337 1.1960 1.2117 1.1935 0.9799 1.1916
SD (+/-) 0.0596 0.1194 0.0447 0.0984 0.1668 0.1337 0.1319 0.0514 0.0452 0.0216 0.0908 0.1129
Hoechst (n=4) NT H202 TNF E35 BBX UA TNF+BBX TNF+UA BBX+TNF E35+BBX E35+UA BBX+E35
AVG (norm) 1.0000 0.7629 0.9501 0.8537 1,0121 1.0246 0.9233 0.9236 0.9610 1.0134 1.0153 0.9684
SD (+/-) 0.0364 0.0486 0.0454 0.0551 0.0685 0.0478 0.0495 0.0555 0.0357 0.0625 0.0606 0.0643
152
Table B.6: Corresponds to Fig 5.9
G F A P  (n=6) 0E 17.4E 35E 50E 100E 200E 400E
AVG (norm) 1.0000 0.9683 1.0795 0.9968 0.9703 0.8684 0.7856
SD  {+/-) 0.0978 0.0429 0.0617 0.0244 0.0650 0.0660 0.1356
H o ech st (n=6) 0E 17.4E 35E 50E 100E 200E 400E
AVG (norm) 1.0000 0.9902 0.9996 0.9976 1.0060 0.9140 0.8809
SD  (+/-) 0.0162 0.0388 0.0256 0.0451 0.0155 0.0471 0.0088
Table B.7: Corresponds to Fig 5.10
C (n=6) NT H 2 0 2 TNF
W G 1338 2903 1869
SD (+/-) 106 280 184
Cb (n=6) NT H 2 0 2 TNF
<\VG 3091 7621 4582
5D (+/-) 123 151 280
Spinal (r>=6) NT H 2 0 2 TNF
*WG 204 787 464
SD (+/-) 25 23 17
DRG (n=6) NT H 202 TNF
W G 208 1006 394
3D (+/-) 27 76 23
Table B.8: Corresponds to Fig 5.11
C  (n=5) NT 1mM H2o2 TNF 17-E 35-E 100-E
AVG (norm) 1.000 4.182 2.716 1.980 2.975 2.043
SD (+/-) 0.063 0.087 0.048 0.106 0.337 0.243
C b(n=5) NT 1 mM H2o2 TNF 17-E 35-E 100-E
AVG (norm) 1.000 5.341 2.989 2.724 3.471 3.250
SD (+/-) 0.091 0.233 0.066 0.191 0.138 0.127
D R G (n=5) NT 1 mM H2o2 TNF 17-E 35-E 100-E
AVG (norm) 1.000 3.160 1.942 1.355 1.909 1.410
SD (+/-) 0.070 0.093 0.024 0.131 0.158 0.062
S (n=5) NT 1 mM H2o2 TNF 17-E 35-E 100-E
AVG (norm) 1.000 3.100 2.253 1.603 2.287 1.690
SD (+/-) 0.063 0.033 0.055 0.105 0.029 0.262
Table B.9: Corresponds to Fig 5.12
Cb-45min NT H202 TNF BBX NP UA BBX+TNF NP+TNF UA+TNF TNF+BBX TNF+NP TNF+UA
W G 3090.8 7620,8 4582.4 2305.0 3104.1 3734.8 2479.2 3445.1 3734.8 4582.4 4582.4 4582.4
SD (+/-) 123.0 151.2 279.5 99.2 278.1 136.1 91.4 193.1 136.1 279.5 279.5 279.5
Cb-dGmin NT H202 TNF BBX NP UA BBX+TNF NP+TNF UA+TNF TNF+BBX TNF+NP TNF+UA
W G 3050.C 10811.1 6360.S 2110.6 2729.7 4194.4 3676.8 4091.7 3802.1 3191.5 3162.4 3287.£
SD (+/-) 101.4 517.7 313.3 238.3 124.6 607.C 234.6 493.9 449.3 230.9 154.0 234.8
Table B.10: Corresponds to Fig 5.13
Cb(n=4) OE 17.4E 35E 50E 100E 200E 400E
AVG (norm) 1.000 3.08285555 4.018 4.098 3.107 2.799 2.704
SD (+/-) 0.178 0.11465568 0.285 0.082 0.043 0.184 0.224
G (n = 4 ) OE 17.4E 35E 50E 100E 200E 40 0 E
AVG (norm) 1 2.77625637 3.405 3.876 4.386 4.516 4.065
SD (+/-) 0.13413216 0.30674905 0.128 0.298 0.188 0.213 0.357
Table B.11: Corresponds to Fig 5.14
Cb (n=6) NT H202 TNF 17-E 35-E 100-E NP TNF+NP NP+TNF E-17+NP E-35+NP E-100+NP
AVG (norm) 1.0000 2.8582 1.7807 2.0105 2.5643 1.9181 0.4422 1.2533 1.0719 0.8724 1.0378 1.2202
SD (+/-) 0.0621 0.1934 0.0738 0.1102 0.2812 0.1003 0.0141 0.1722 0.1603 0.1710 0.1804 0.1540
DRG (n=6) NT H202 TNF 17-E 35-E 100-E NP TNF+NP NP+TNF E-17+NP E-35+NP E-100+NPiiI 1.0000 2.7990] 2.0681 1.2822 1.5697 1.5415 0.5127 1.4089 1.2546 0.8087 1.0356 1.4009*
SD (+/-) 0.1148 0.0583 0.1984 0.2092 0.2162 0.1364 0.0184 0.1598 0.1646 0.1531 0.0922 0.0355
Glial (rv=6) NT H202 TN F 17-E 35-E 100-E NP TNF+NP NP+TNF E-17+NP E-35+NP E-100+NP
AVG (norm) 1.0000 2.1503 1.4783 1.5687 1.7473 1.9218 0.6382 1.0694 1.1057 0.7546 0.8287 1.2402
SD (+/-) 0.0233 0.1125 0.0766 0.0504 0.1875 0.1571 0.1257 0.0264 0.1250 0.0998 0.0548 0.0990
Table B.12: Corresponds to Fig 5.15
155
B erry fractions (n=3) BLK B B X NP P UA
AVG (uM Trolox equiv) 0.0000 1195.3125 726.5625 695.3125 31.2500
SD (+/-) 0.0001 117.6942 69.5648 71.0025 1.9982
Table B.13: Corresponds to Fig 5.16
Celt type (n =3 ) C C b S OB D R G G
AVG (uM Trolox equiv) 2.3392 2 .3403 2.3393 2 .3167 2 .3400 2.3565
SD (+/-) 0 .0012 0.0023 0.0021 0.0000 0.0006 0.0001
Table B.14: Corresponds to Fig 5.17
Treatm ent (n®3) B LK B B X N P P U A E 35
AVG (uM Trolox equiv) 1.0000 6.6784 4 .4516 4.3031 1.1485 2.1134
SD {+/-) 0 .0992 0.5850 0 .4242 0.4409 0.0740 0.1999
Table B.15: Corresponds to Fig 5.18
Cb (n=3) NT TNF E17 E35 E100 BBX NP UA TNF+BBX TNF+NP E35+BBX E35+NP E35+UA
AVG 2.3403 4.4935 5.3772 5.6717 0.8605 7.5373 8.0283 11.4649 7.4391 6.0645 6.2609 8,6174 7.0464
SD (+/-) 0.0003 0.7423 0.6098 0.2121 0.5567 0.4507 0.4242 1.9353 0.1060 0.7423 0.1060 0.5302 0.1591
G (n=3) NT TNF E17 E35 E100 BBX NP UA TNF+BBX: TNF+NP E35+BBX E35+NP E35+UA
AVG 2.3565 4.9108 7.4883 7.2901 7.0257 10.0659 9.8676 9.4050 5.9022 4.6465 6.9596 8.2153 8.6119
SDW -} 0.0000 0.1606 0.3569 0.0892 0.0178 0.2320 0.0000 0.0535 0.2141 1.0171 0.2855 0.6959 0.0892
Table B.16: Corresponds to Fig 5.19
Cb (n=4) NT H 202 TNF E35 BBX NP UA TNF+BBX TNF+NP TNF+UA E35+BBX E35+NP E35+UA
AVG 0.8059 1.4346 1.1393 1.8924 0.2026 0.3587 0.0971 0.1688 0.1266 0.1688 0.1561 0.1013 0.5612
SD ; + , - _ 0.1088 0.0459 0.0382 0.1168 0.0333 0.1005 0.1018 0.0929 0.0795 0.0419 0.1912 0.1044 0.0801
157
Table B.17: Corresponds to Fig 5.20
Cb (n-3) NT MBCD E35 MBCD+E35
AVG 0.8059 -0 .0500 1.8924 -0 .0422
SD (+/-) 0 .1088 0.0038 0.1907 0.001401
Table B.18: Corresponds to Fig 5.21
Cb (n=3) 0E 17.4E 35E 50E 100E 200E 400E
AVG 0.0000 1.6519 1.8924 1.6836 1.3861 1.2696 1.3285
SD (+/-) 0.0004 0.0850 0.0650 0.0700 0.0225 0.0130 0.0195
Table B.19: Corresponds to Fig 5.22
G (n=3) NT 1 M H 2 0 2 E-35 BBX UA E-35+ BBX E-35+UA
AVG 37.4601 69.7921 52.0563 27 .7768 27.9714 33.5254 32.5937
SD (+/-) 1.4867 2 .1229 2 .7926 0 .8673 2.1363 2.5005 1.3092
Cb (n=3) NT 1 M H 2 0 2 E-35 BBX UA E-35+ BBX E-35+UA
AVG 17.2763 38.6469 29.9956 13.0754 11.4381 18.7361 18.2926
SD (+/-) 1.2070 0.6470 1.0319 0.6855 1.0289 0.6541 1.3512
Table B.20: Corresponds to Fig 5.23
G (n=3) NT 1 M H 2 0 2 E-35 BBX UA E-35+ BBX E-35+UA
AVG 4.2377 4.3381 4 .2577 4 .2236 4 .2248 4.2185 4.2209
SD (+/-) 0.0221 0.0019 0.0221 0.0211 0 .0222 0.0380 0.0231
Cb (n=3) NT 1 M H 2 0 2 E-35 BBX UA E35+BBX E35+UA
AVG 4.1809 4.2921 4.2411 4 .1893 4 .1897 4 .1802 4.1864
SD (+/-) 0 .0013 0.0302 0.0325 0.0228 0.0390 0.0223 0.0082
Table B.21: Corresponds to Fig 5.24
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G  (n = 3 ) E -0 E -1 7 .4 E -3 5 E -5 0 E -1 0 0 E -2 0 0 E -4 0 0
AVG 4.2377 4.2569 4.2577 4.2768 4.2807 4.2966 4.3719
SD (+/-) 0.0682 0.0921 0.1235 0.4023 0.4294 0.1547 0.3965
Table B.22: Corresponds to Fig 5.25
C b (n=3) N T M B C D E 35 M B C D + E 3 5
AVG 15.9043 11.5425 28.9291 12.2669
SD (+/-) 1.1322 1.0346 1.2055 1.0075
Table B.23: Corresponds to Fig 5.27
Cb(n=8) NT MBCD H202 TNF E35 BBX UA BBX+TNF BBX+E35 TNF+BBX E35+BBX UA+TNF UA+E35 TNF+UA E35+UA
AVG 1.0000 0.5321 1.5179 1.5380 1.3834 0.4590 0.4858 0.4127 0.3493 0.5095 0.4328 0.3852 0.3997 0.3613 0.4557
SD  ( * ! - ) 0.1090 0.0701 0.3186 0.2377 0.1395 0.0795 0.1019 0.0873 0.0408 0.0922 0.0652 0.0501 0.0423 0,0554 0.0687
Table B.24. Corresponds to Fig 5.28
G  (n=8) EO E17.4 E35 E50 E100 E200 E400
AVG (norm) 1.0000 1.6802 1.9752 1.0790 0.9054 1.1206 0.6985
SD (+/-) 0.1674 0.2881 0.1740 0.1283 0.0929 0.1528 0.0734
Cb (n=6) EO E17 E35 E50 E100 E200 E400
AVG (norm) 1.0000 1.4250 1.3834 1.3370 1.3183 1.2374 1.4554
SD (+/-) 0 .1090 0.1208 0.1395 0.1345 0.1441 0.0815 0 .1579
Table B.25: Corresponds to Fig 5.30
Cb
(n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
MBCD*
TNF
MBCDf
E35
AVG
(norm) 1.0000 0.6883 2.0861 1.6252 1.6345 0.8453 0.8675 1.0148 1.1734 1.1782 0.9263 1.1032 1.1714 0.8157 0.7168
SD
- - 0.1217 0.1357 0.1142 0.1055 0.2409 0.1798 0.1194 0.1383 0.2389 0.0948 0.1014 0.0972 0.1758 0.0871 0.0478
Table B.26: Corresponds to Fig 5.33
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LR  (n=6) 0E 17.4E 3 5 E 5 0 E 100E 2 0 0 E 4 0 0 E
AVG (norm) 1.0000 1.1747 1.2388 1.1680 0.8875 0.8365 0.8324
SD (+/-) 0 .1217 0.1260 0.0897 0.0764 0.0886 0.0926 0.0900
Nav(n=6) 0E 17.4E 35E 50E 100E 200E 400E
AVG (norm) 1.0000 1.0480 1.8150 1.6505 1.1575 1.0647 0.6426
SD (+/-) 0 .1722 0 .1256 0 .1905 0.1181 0 .2322 0 .2 2 3 2 0 .1454
ROS (n=4) OE 17.4E 35E 50E 100E 200E 400E
AVG (norm) 1.0000 3 .0829 4 .0183 4.0981 3.1067 2.7993 2 .7039
SD (+/-) 0 .1782 0 .1147 0 .2847 0.0821 0 .0430 0.1838 0.2245
Table B.27: Corresponds to 5.34
LR(n=4) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG (norm) 1.0000 0.7483 2.4084 1.7315 1.8891 0.8737 0.6821 1.0635 1.1619 1.2476 1.0392 1.2115 1,3153
SD (+/-) 0.1856 0.1272 0.1180 0.1273 0.1906 0.1905 0.3406 0.1780 0,1707 0.1213 0.1864 0.1493 0.1323
Nav (n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG (norm) 1.0000 0.2586 2.0630 1.5934 1.4279 0.4617 0.5252 0.9076 1.0467 08239 0.7286 0.7315 0.8735
"SD(+/-) . 0.0995 0.0464 0.1243 0.2052 0.1574 0.0959 0.0763 0.1464 0.1654 0.1204 0.1169 0.0694 0.2495
Table B.28: Corresponds to Fig 5.35
Whole
(n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG
(norm) 1.0000 0.6883 2,0861 1.6252 1.6345 0.8453 0.8675 1.0148 1.1734 1.1782 0.9263 1.1032 1.1714
SD (+/-) 0.1217 0.1357 0.1142 0.1055 0.2409 0.1798 0.1194 0.1383 0.2389 0.0948 0.1014 0.0972 0.1758
Membrane
(n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+-
UA
BBX+
E35
AVG
fnorm) 0.8026 0.6006 1.9331 1.3898 1.5163 0.7013 0.5475 0.8536 0.9326 1.0013 0.8341 09724 1.0557
SD (+/-) 0.1856 0.1272 0.1180 0.1273 0.1906 0.1905 0.3406 0.1780 0.1707 0.1213 0.1864 0.1493 0.1323
Cytosd
(n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
8BX
E35+
UA
BBX+
E35
AVG
(norm) 0.0691 0,0046 0.0162 0.0066 0.0105 0.0064 0.0064 0.0076 0.0094 0.0125 0.0064 0.0111 0.0097
SD (+/-) 0.5310 0.5301 0.4061 0.4287 0.3460 0.6813 0.6039 0.5076 0.4797 0.1680 0.6749 0,3975 0.1929
Table B.29: Corresponds to Fig 5.36
Membrane
(n=3) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG 0.0100 0.0027 0.0204 00155 0.0135 0.0046 0.0045 0.0091 0.0094 0.0082 00063 0.0063 0.0081
SD (+/-) 0.0010 0.0015 0.0006 0.0012 0.0009 0.0010 0.0009 0.0014 0.0017 0.0010 0.0012 0,0007 0.0020
Cytosol
<n=3) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG 0.0016 0.0027 0.0011 0.0012 0.0006 0.0040 0.0032 0.0009 0.0013 0.0022 0.0015 0.0017 0.0025
SD (+/-) 0.0006 0.0005 0.0003 0.0005 0.0008 0.0007 0.0007 0.0001 0.0005 0.0002 0.0002 0.0001 0.0010
Table B.30: Corresponds to Fig 5.37
Whole
(n=6) NT MBCD H202 TNF E35 BBX UA
TNF+
BBX
TNF+
UA
UA+
TNF
E35+
BBX
E35+
UA
BBX+
E35
AVG 1.0000 0.4549 1.8819 1.4860 1.2851 0.7415 0.7329 0.8606 1.0190 0.9010 0.7596 0.7786 0.9679
SD (+/-) 0.1722 0.2256 0.2413 0.1867 0.1879 0.0421 0.1179 0.0962 0.2441 0.0404 0.0334 0.0298 0,0879
Table B.31: Corresponds to Fig A. 1
SH45-min
(n=5) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 276.88 1212.21 493.07 277.57 316.53 310.25 277,57 316.53 310.25 493.07 493.07 493.07
SD (+/-) 82.76 163.75 8.55 36.24 16.89 17.84 36.24 16.89 17.84 8.55 8.55 8.55
90-mirt
(n=5) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 209.11 1099.10 457.28 236.12 303.00 29651 170.57 199.19 214.46 151.38 162.15 105.86
SD (+/-) 5.94 96.18 18.54 31.07 52.38 15.75 6.3S 17.32 12.68 6.37 12,29 3.56
Table B.32: Corresponds to Fig A.2
C 45 min
|n=6) . . . NT H2G2 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
W G 1338.08 2902 58 1869.45 729.02 1140.18 1190.33 838.77 1096.28 1172.77 186945 1869.45 1869.45
SD (+/-) 105.86 279.9a 183.7C 52.91 64.18 65.81 173.91 83.34 68.3C 183.70 183.70 183.7C
C 90 min 
|n=6) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
W G 1305.04 3965.67 2434.11 777.80 1072.74 1147.59 1441.32 1427.46 1550.98 1356.76 1244.96 1350.31
SD (+/-) 109.07 179.56 135.11 75.34 81.55 66.83 99.65 97.05 69.57 102.22 64.89 87.52
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Table B.33: Corresponds to Fig A.3
S 45-min
<n=6) . NT H202 TNF BBX NP UA
BBX+
TNF
N P+
TNF
UA*
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 204.31 787 12 463.68 126.64 190.68 207.73 126.64 190.68 207.73 463.68 463.68 463.68
SD (+/-) 24.74 23.44 16.69 12.47 19.52 26.65 12.47 19.52 26.65 16.69 16.69 16.69
S 90-min 
(n=6) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 178.38 986.44 582.40 122.98 179.34 197.71 251.86 268.73 276.64 230.85 230.96 268.14
SD {+/-) 37.21 13.17 44.17 11.93 16.80 4 .32 37.64 51 42 33.88 23.12 27.85 34.65
Table B.34: Corresponds to Fig A.4
D R G  45-mtn 
(n=6) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 213.71 882.70 420.57 190.16 201.99 166.92 190.16 201.99 166.92 420.57 420.57 420.57
SD {+/-) 31.96 15.94 15.71 13.97 1 76 13.34 13.97 1 76 13.34 15.71 15.71 15.71
D RG  90-min 
(n=6) NT H202 TNF BBX NP UA
BBX+
TNF
NP+
TNF
UA+
TNF
TNF+
BBX
TNF+
NP
TNF+
UA
AVG 207.55 1006.32 582.11 181.59 202.12 156.94 290.12 276.66 2 9 7 7 5 253.86 253.20 276.80
SD (+/-) 26.70 75.64 19.79 16.25 4.41 10.59 18.16 3.35 25.27 3.93 4.34 29.38
Table B.35: Corresponds to Fig A.5
C (n=5) NT H202 TNF 17-E 35-E 100-E BBX UA TNF+BBX TNF+UA BBX+TNF UA+TNF
AVG (norm) 1.0000 4.1816 2.7157 1.9803 2.9749 2.0433 1.0687 1.4742 1.7335 1.4216 1.9723 1.8753
SD (+/-) 0.0633 0.0870 0.0477 0.1058 0.3373 0.2432 0.1156 0.1279 0.2945 0.1164 0.1805 0.1614
Cb (n=5) NT H202 TNF 17-E 35-E 100-E BBX UA TNF+BBX TNF+UA BBX+TNF UA+TTSIF
AVG (norm) 1.0000 5.3410 2.9892 2.7245 3.4715 3.2499 1.8343 1.7240 1.9654 1.5658 2.3423 2 6424
SD (+/-) 0.0912 0.2327 0.0659 0.1913 0.1380 0.1266 0.2191 0.0742 0.1741 0.0543 0.1578 0.4484
DRG (n=5) NT H202 TNF 17-E 35-E 100-E BBX UA TNF+BBX TNF+UA BBX+TNF UA+TNF
AVG (norm) 1.0000 3.1599 1.9420 1.3546 1.9093 1.4095 1.0057 1.0445 1.3130 1.2922 1,3345 1.4137
SD (+/-) 0.0702 0.0932 0.0239 0.1310 0.1582 0.0624 0.0703 0.0846 0.0701 0.0633 0.0833 0.1185
S (n=5)___ NT H202 TNF 17-E 35-E 100-E BBX UA TNF+BBX TNF+UA BBX+TNF UA+TNF
AVG (norm) 1.0000 3.0999 2.2527 1.6033 2.2870 1.6900 0.7405 1.0145 0.6732 0.9534 1.1921 0,8094
SD (+/-) 0.0633 0.0335 0.0548 0.1045 0.0290 0.2621 0.0446 0.0547 0.0375 0.0478 0.0270 0.0833
E-17+
BBX
E-17+
UA
BBX+
E-17
UA+E-
17
E-35+
BBX
E-35+
UA
BBX+
E-35
UA+
E-35
E-100+
BBX
E-100+
UA
BBX+
E-100
UA+
E-100
AVG (norm) 0.7001 0.7767 0.5011 0.7921 0.6755 1.3465 1.4976 1.3973 1.1076 1.3731 1.4988 1.9583
SD(+/-) 0.0976 0.0721 0.0310 0.1455 0.0720 0.2072 0.0777 0.0467 0.0599 0.0353 0.0684 0.3438
Cb (n=5)
E-17+
BBX
E-17+
UA
BBX+
E-17
UA+Er
17
E-35+
BBX
E-35+
UA
BBX+
E-35
UA+
E-35
E-1QQ+
BBX
E-1CQ+
UA
BBX+
E-100
UA+
E-100
AVG (norm) 1.6206 2.0063 1.4044 2.3412 1.4007 1.9362 2.4426 2.3893 2.4386 3.1090 3.1558 3,1640
SD (+/-) 0.0923 0.1543 0.1173 0.0621 0.2847 0.1675 0.2600 0.3121 0.1510 0.1864 0.2583 0.0803
DRG (n=5)
E-17+
BBX
E-17+
UA
BBX+
E-17
UA+
E-17
E-35+
BBX
E-35+
UA
BBX+
E-35
UA+
E-35
E-100+
BBX
E-100+
A
BBX+
E-100
UA+
E-100
AVG (norm) 0.8778 1.0106 1.2123 1.2161 0.7507 1.0471 0.9241 0.9441 0.9432 0.9464 0.9340 0.9853
SD (+/-) 0.0505 0.0838 0.0794 0.1943 0.0600 0.0674 0.0638 0.1032 0.0828 0.1921 0.0928 0,2292
S (n=5)
E-17+
BBX
E-17+
UA
BBX+
E-17
UA+
E-17
E-35+
BBX
E-35+
UA
BBX+
E-35
UA+
E-35
E-100+
BBX
E-10CN-
UA
BBX+
E-100
UA+
E-100
AVG (norm) 0.8868 0.9618 0.8801 0.8691 0.6239 0.9661 0.9654 1.0098 0.9400 1.0279 1.0181 0,7590
SD (+/-) 0.1403 0.1167 0.1296 0.0175 0.0415 0.3537 0.0306 0.0454 0.0756 0.0675 0.0940 0.0365
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